Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Regulation Of Cell Adhesion Molecule Production (GO:0060353),2/6,0.00139661368717992,0.384524154642484,0,0,51.0309278350515,335.462253586082,CXCL8;NOTCH4
Regulation Of Transcription By RNA Polymerase III (GO:0006359),3/26,0.00204092534218192,0.384524154642484,0,0,13.3685514755576,82.809513233667,NAB2;DDX21;MAF1
Glycosaminoglycan Metabolic Process (GO:0030203),3/28,0.0025348708918474,0.384524154642484,0,0,12.2978238341969,73.5116263776598,HYAL2;GUSB;CLN6
Negative Regulation Of Mitochondrial Outer Membrane Permeabilization Involved In Apoptotic Signaling Pathway (GO:1901029),2/10,0.00408297961837735,0.384524154642484,0,0,25.5103092783505,140.330381191905,SLC25A5;SLC25A6
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),9/319,0.00433757024389394,0.384524154642484,0,0,3.02649646368811,16.4654752636429,PSMB6;DNAJB2;KLHDC3;RNF126;HSPA5;UBXN11;DNAJB9;FBXL15;ZNF598
Positive Regulation Of Protein Localization To Nucleus (GO:1900182),4/72,0.00547655388034308,0.384524154642484,0,0,6.04656862745098,31.4861712251998,TRIM28;HYAL2;SESN2;MEPCE
Negative Regulation Of Mitochondrial Membrane Permeability (GO:0035795),2/12,0.0059116845123651,0.384524154642484,0,0,20.4061855670103,104.700556056877,SLC25A5;SLC25A6
Negative Regulation Of Mitochondrion Organization (GO:0010823),3/39,0.00653561128945496,0.384524154642484,0,0,8.53540587219344,42.9372687257651,GPX1;SLC25A5;SLC25A6
Negative Regulation Of Endoplasmic Reticulum Unfolded Protein Response (GO:1900102),2/13,0.00694171038039362,0.384524154642484,0,0,18.5501405810684,92.198040094087,HSPA5;DNAJB9
Suppression Of Viral Release By Host (GO:0044790),2/13,0.00694171038039362,0.384524154642484,0,0,18.5501405810684,92.198040094087,MARCHF2;TRIM28
Regulation Of IRE1-mediated Unfolded Protein Response (GO:1903894),2/13,0.00694171038039362,0.384524154642484,0,0,18.5501405810684,92.198040094087,HSPA5;DNAJB9
Fatty Acid Metabolic Process (GO:0006631),5/122,0.00706782958749475,0.384524154642484,0,0,4.40484181321878,21.8136657113788,GGT5;FAAH;GPX1;NAAA;ALKBH7
Cellular Response To Glucose Starvation (GO:0042149),3/42,0.00803575892328907,0.384524154642484,0,0,7.87764049422081,38.0005862857181,HSPA5;SESN2;PICK1
Negative Regulation Of Transcription Elongation By RNA Polymerase II (GO:0034244),2/14,0.00804674144004824,0.384524154642484,0,0,17.0034364261168,81.9988691363917,RECQL5;NELFA
Aminoglycan Catabolic Process (GO:0006026),2/14,0.00804674144004824,0.384524154642484,0,0,17.0034364261168,81.9988691363917,HYAL2;GUSB
Post-Translational Protein Targeting To Endoplasmic Reticulum Membrane (GO:0006620),2/14,0.00804674144004824,0.384524154642484,0,0,17.0034364261168,81.9988691363917,UBL4A;HSPA5
Cellular Response To Starvation (GO:0009267),5/126,0.00807169918832231,0.384524154642484,0,0,4.25836181904721,20.5227117440903,KLF10;MAP1LC3A;HSPA5;SESN2;PICK1
Negative Regulation Of Apoptotic Signaling Pathway (GO:2001234),4/82,0.00863446524232799,0.384524154642484,0,0,5.26869658119658,25.0368118988297,NR4A2;GPX1;SLC25A5;SLC25A6
Embryonic Organ Morphogenesis (GO:0048562),3/44,0.00913923960790987,0.384524154642484,0,0,7.49260710223683,35.1791247098431,PPP1R35;HES1;FUZ
Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),3/44,0.00913923960790987,0.384524154642484,0,0,7.49260710223683,35.1791247098431,TRIM28;HYAL2;EMD
Glycosaminoglycan Catabolic Process (GO:0006027),2/15,0.009225224046054,0.384524154642484,0,0,15.6946867565424,73.5423798299613,HYAL2;GUSB
Regulation Of Fibrinolysis (GO:0051917),2/16,0.0104756275208102,0.384524154642484,0,0,14.5729013254786,66.4335422298719,PLAU;F12
Regulation Of Plasminogen Activation (GO:0010755),2/16,0.0104756275208102,0.384524154642484,0,0,14.5729013254786,66.4335422298719,PLAU;F12
Regulation Of Receptor Signaling Pathway Via STAT (GO:1904892),2/17,0.0117964438701311,0.384524154642484,0,0,13.6006872852234,60.3864688911627,TP53INP2;HES1
Regulation Of DNA Methylation-Dependent Heterochromatin Formation (GO:0090308),2/17,0.0117964438701311,0.384524154642484,0,0,13.6006872852234,60.3864688911627,TRIM28;SAMD1
Regulation Of Mitochondrial Outer Membrane Permeabilization Involved In Apoptotic Signaling Pathway (GO:1901028),2/18,0.0131861874799938,0.384524154642484,0,0,12.75,55.1894638536014,SLC25A5;SLC25A6
Negative Regulation Of DNA-templated Transcription, Elongation (GO:0032785),2/18,0.0131861874799938,0.384524154642484,0,0,12.75,55.1894638536014,RECQL5;NELFA
RNA Modification (GO:0009451),3/51,0.0136723927186284,0.384524154642484,0,0,6.39766839378238,27.4612021674109,MEPCE;TSR3;ELP5
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:0042771),2/19,0.0146433948332494,0.384524154642484,0,0,11.9993935718617,50.6826295072671,DDIT4;CDIP1
Response To Fibroblast Growth Factor (GO:0071774),2/20,0.0161666242170096,0.384524154642484,0,0,11.3321878579611,46.7430809510973,CXCL8;HYAL2
Positive Regulation Of Blood Coagulation (GO:0030194),2/21,0.0177544554426093,0.384524154642484,0,0,10.735214324471,43.2749241105001,PLAU;F12
mRNA Transport (GO:0051028),3/58,0.019277169977709,0.384524154642484,0,0,5.58144135657089,22.0401842031944,NXT1;ALYREF;EIF4A3
Positive Regulation Of Cilium Assembly (GO:0045724),2/22,0.0194054895710846,0.384524154642484,0,0,10.1979381443299,40.2023044647121,PPP1R35;FUZ
mRNA Export From Nucleus (GO:0006406),3/62,0.0229689864415602,0.384524154642484,0,0,5.20198471941688,19.6302635783619,NXT1;ALYREF;EIF4A3
RNA Export From Nucleus (GO:0006405),3/65,0.0259720922784299,0.384524154642484,0,0,4.94952365034264,18.0693877968937,NXT1;ALYREF;EIF4A3
Establishment Or Maintenance Of Apical/Basal Cell Polarity (GO:0035088),2/26,0.0266144044353898,0.384524154642484,0,0,8.49656357388316,30.8111113406371,PARD6A;LLGL1
Response To Reactive Oxygen Species (GO:0000302),3/66,0.0270176860037823,0.384524154642484,0,0,4.8707130520602,17.5894287034307,PLK3;GPX1;HYAL2
GPI Anchor Metabolic Process (GO:0006505),2/27,0.0285611933432688,0.384524154642484,0,0,8.15628865979381,29.0013674506608,PIGQ;TP53INP2
Chaperone Cofactor-Dependent Protein Refolding (GO:0051085),2/27,0.0285611933432688,0.384524154642484,0,0,8.15628865979381,29.0013674506608,SDF2L1;HSPA5
Positive Regulation Of TORC1 Signaling (GO:1904263),2/27,0.0285611933432688,0.384524154642484,0,0,8.15628865979381,29.0013674506608,SESN2;GPR137
Aerobic Electron Transport Chain (GO:0019646),3/68,0.0291755428461572,0.384524154642484,0,0,4.72036667995217,16.6837796163167,NDUFA6;NDUFS7;CYC1
Positive Regulation Of Protein Import Into Nucleus (GO:0042307),2/28,0.0305632223934706,0.384524154642484,0,0,7.84218873909596,27.3532239731398,TRIM28;HYAL2
Mitochondrial ATP Synthesis Coupled Electron Transport (GO:0042775),3/70,0.0314220206793674,0.384524154642484,0,0,4.57899621065656,15.8444548620367,NDUFA6;NDUFS7;CYC1
Regulation Of Cellular Biosynthetic Process (GO:0031326),3/70,0.0314220206793674,0.384524154642484,0,0,4.57899621065656,15.8444548620367,CXCL8;RPL10;ELP5
Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903320),2/29,0.0326192337961978,0.384524154642484,0,0,7.55135547919053,25.8471810460795,DNAJB2;GPS1
Modified Amino Acid Transport (GO:0072337),2/29,0.0326192337961978,0.384524154642484,0,0,7.55135547919053,25.8471810460795,SLC5A6;SLC7A7
Regulation Of Blood Coagulation (GO:0030193),2/29,0.0326192337961978,0.384524154642484,0,0,7.55135547919053,25.8471810460795,PLAU;F12
Negative Regulation Of Growth (GO:0045926),4/124,0.0338356102884207,0.384524154642484,0,0,3.41736111111111,11.5720099201594,DNAJB2;HYAL2;SESN2;OSGIN1
Negative Regulation Of Cell Growth (GO:0030308),4/125,0.0346958964011752,0.384524154642484,0,0,3.38894628099174,11.3907020891863,DNAJB2;HYAL2;SESN2;OSGIN1
GPI Anchor Biosynthetic Process (GO:0006506),2/30,0.0347279889003515,0.384524154642484,0,0,7.28129602356406,24.4666787644392,PIGQ;TP53INP2
Cytoplasmic Translational Initiation (GO:0002183),2/30,0.0347279889003515,0.384524154642484,0,0,7.28129602356406,24.4666787644392,EIF4A1;EIF3I
Embryonic Skeletal System Morphogenesis (GO:0048704),2/30,0.0347279889003515,0.384524154642484,0,0,7.28129602356406,24.4666787644392,EIF4A3;FUZ
Negative Regulation Of Blood Coagulation (GO:0030195),2/30,0.0347279889003515,0.384524154642484,0,0,7.28129602356406,24.4666787644392,PLAU;F12
Ubiquitin-Dependent ERAD Pathway (GO:0030433),3/73,0.0349569801796712,0.384524154642484,0,0,4.3820873427091,14.6959307371418,DNAJB2;HSPA5;DNAJB9
Positive Regulation Of Intracellular Protein Transport (GO:0090316),4/126,0.0355688220849094,0.384524154642484,0,0,3.36099726775956,11.2132474884431,PLK3;TRIM28;HYAL2;EMD
Non-Motile Cilium Assembly (GO:1905515),2/31,0.0368882679194036,0.384524154642484,0,0,7.0298613579808,23.1975703995154,FUZ;ENKD1
Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),2/31,0.0368882679194036,0.384524154642484,0,0,7.0298613579808,23.1975703995154,HYAL2;G0S2
'De Novo' Post-Translational Protein Folding (GO:0051084),2/32,0.0390988696860769,0.384524154642484,0,0,6.79518900343643,22.0277040773149,SDF2L1;HSPA5
Regulation Of Transcription By RNA Polymerase I (GO:0006356),2/32,0.0390988696860769,0.384524154642484,0,0,6.79518900343643,22.0277040773149,DDX21;MAF1
Membrane Protein Proteolysis (GO:0033619),2/34,0.0436663285063957,0.384524154642484,0,0,6.36984536082474,19.9451195846475,SPPL2B;CLPP
Mitochondrial Electron Transport, NADH To Ubiquinone (GO:0006120),2/34,0.0436663285063957,0.384524154642484,0,0,6.36984536082474,19.9451195846475,NDUFA6;NDUFS7
Establishment Of Spindle Orientation (GO:0051294),2/35,0.0460208741813538,0.384524154642484,0,0,6.1765073414558,19.0153673201798,LLGL1;ENKD1
Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:0072332),2/35,0.0460208741813538,0.384524154642484,0,0,6.1765073414558,19.0153673201798,DDIT4;CDIP1
DNA-templated Transcription (GO:0006351),5/199,0.0465336439597851,0.384524154642484,0,0,2.64613806876451,8.11723942840689,NR4A2;SNAPC2;TAF13;DDX21;POLRMT
Negative Regulation Of Fibroblast Migration (GO:0010764),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,HYAL2
Negative Regulation Of Glial Cell Proliferation (GO:0060253),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,HES1
DNA Methylation Involved In Embryo Development (GO:0043045),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,PICK1
Golgi Disassembly (GO:0090166),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,PLK3
Regulation Of Glutamate Receptor Signaling Pathway (GO:1900449),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,NECAB2
Attachment Of GPI Anchor To Protein (GO:0016255),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,TP53INP2
Notochord Development (GO:0030903),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,PPP1R35
Basic Amino Acid Transport (GO:0015802),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,SLC7A7
Regulation Of pro-B Cell Differentiation (GO:2000973),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,HES1
Peptidyl-Diphthamide Biosynthetic Process From Peptidyl-Histidine (GO:0017183),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,DPH7
Peptidyl-Diphthamide Metabolic Process (GO:0017182),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,DPH7
Regulation Of Translation In Response To Endoplasmic Reticulum Stress (GO:0036490),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,SESN2
Response To Lithium Ion (GO:0010226),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,IMPA2
Embryonic Brain Development (GO:1990403),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,RPL10
snRNA Modification (GO:0040031),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,MEPCE
Positive Regulation Of Hemoglobin Biosynthetic Process (GO:0046985),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,PRMT1
Positive Regulation Of Protein Catabolic Process In The Vacuole (GO:1904352),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,MARCHF2
Positive Regulation Of Tau-Protein Kinase Activity (GO:1902949),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,NAB2
Positive Regulation Of Transcription Of Notch Receptor Target (GO:0007221),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,NOTCH4
Positive Regulation Of Urine Volume (GO:0035810),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,HYAL2
Radial Glial Cell Differentiation (GO:0060019),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,HES1
Negative Regulation Of Arp2/3 Complex-Mediated Actin Nucleation (GO:0034316),1/5,0.0480534454514014,0.384524154642484,0,0,25.3846153846154,77.0535134919584,PICK1
DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330),2/36,0.0484211193778821,0.384524154642484,0,0,5.99454214675561,18.1503898650043,PLK3;SESN2
Ribosomal Small Subunit Biogenesis (GO:0042274),3/84,0.0495834498969151,0.384524154642484,0,0,3.7848781423911,11.3701455101818,TBL3;SPPL2B;TSR3
Spliceosomal snRNP Assembly (GO:0000387),2/37,0.050865952454686,0.384524154642484,0,0,5.82297496318115,17.344088981186,TSSC4;STRAP
Cellular Respiration (GO:0045333),3/85,0.0510399495212423,0.384524154642484,0,0,3.73853153039302,11.122679479872,NDUFA6;NDUFS7;CYC1
Positive Regulation Of Protein Localization (GO:1903829),3/85,0.0510399495212423,0.384524154642484,0,0,3.73853153039302,11.122679479872,NECAB2;PARD6A;SESN2
G2/M Transition Of Mitotic Cell Cycle (GO:0000086),2/38,0.0533542789639779,0.384524154642484,0,0,5.66093928980527,16.5910870915956,PLK3;FBXL15
Regulation Of Protein Import Into Nucleus (GO:0042306),2/38,0.0533542789639779,0.384524154642484,0,0,5.66093928980527,16.5910870915956,TRIM28;HYAL2
Maturation Of SSU-rRNA (GO:0030490),2/38,0.0533542789639779,0.384524154642484,0,0,5.66093928980527,16.5910870915956,SPPL2B;TSR3
Anterograde Axonal Transport (GO:0008089),2/39,0.0558850214458444,0.384524154642484,0,0,5.50766230147673,15.8866254742654,BLOC1S4;MAPK8IP3
Carboxylic Acid Transmembrane Transport (GO:1905039),2/39,0.0558850214458444,0.384524154642484,0,0,5.50766230147673,15.8866254742654,SLC5A6;SLC7A7
ERAD Pathway (GO:0036503),3/89,0.0570710634973898,0.384524154642484,0,0,3.56392336426075,10.2051450813433,DNAJB2;HSPA5;DNAJB9
Regulation Of Centriole Elongation (GO:1903722),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,PPP1R35
Regulation Of Entry Of Bacterium Into Host Cell (GO:2000535),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,CXCL8
Regulation Of Hemoglobin Biosynthetic Process (GO:0046984),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,PRMT1
Negative Regulation Of Oligodendrocyte Differentiation (GO:0048715),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,HES1
Negative Regulation Of Plasminogen Activation (GO:0010757),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,PLAU
Neurotrophin TRK Receptor Signaling Pathway (GO:0048011),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,DDIT4
Peptidyl-Arginine Modification (GO:0018195),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,PRMT1
Cellular Hyperosmotic Response (GO:0071474),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,YBX3
Pharyngeal Arch Artery Morphogenesis (GO:0061626),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,HES1
Ribosome-Associated Ubiquitin-Dependent Protein Catabolic Process (GO:1990116),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,ZNF598
Glucan Catabolic Process (GO:0009251),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,GAA
Positive Regulation Of Mitophagy (GO:1901526),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,SLC25A5
Glutathione Biosynthetic Process (GO:0006750),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,HAGH
Glycogen Catabolic Process (GO:0005980),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,GAA
Vascular Associated Smooth Muscle Cell Development (GO:0097084),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,HES1
Hemostasis (GO:0007599),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,VWF
Positive Regulation Of Protein Localization To Centrosome (GO:1904781),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,PARD6A
Inositol Metabolic Process (GO:0006020),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,IMPA2
Long-Term Synaptic Depression (GO:0060292),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,PICK1
Monoacylglycerol Catabolic Process (GO:0052651),1/6,0.0573848327319046,0.384524154642484,0,0,20.3066666666667,58.0359507168085,FAAH
Notch Signaling Pathway (GO:0007219),2/40,0.0584571191758676,0.384524154642484,0,0,5.36245252306023,15.2264790885291,NOTCH4;HES1
Cell Cycle G2/M Phase Transition (GO:0044839),2/40,0.0584571191758676,0.384524154642484,0,0,5.36245252306023,15.2264790885291,PLK3;FBXL15
Establishment Or Maintenance Of Epithelial Cell Apical/Basal Polarity (GO:0045197),2/40,0.0584571191758676,0.384524154642484,0,0,5.36245252306023,15.2264790885291,PARD6A;LLGL1
Neuron Development (GO:0048666),4/150,0.0603143438012347,0.384524154642484,0,0,2.8050799086758,7.87718424776595,BLOC1S4;PRMT1;STMN3;HS6ST1
protein-RNA Complex Assembly (GO:0022618),4/150,0.0603143438012347,0.384524154642484,0,0,2.8050799086758,7.87718424776595,TSSC4;RPL10;EIF3I;STRAP
Heart Contraction (GO:0060047),2/41,0.0610695279683412,0.384524154642484,0,0,5.22468939994713,14.606884956716,GPX1;GAA
Regulation Of Amide Metabolic Process (GO:0034248),2/41,0.0610695279683412,0.384524154642484,0,0,5.22468939994713,14.606884956716,RPL10;ELP5
Cytoplasmic Translation (GO:0002181),3/93,0.0634238644056201,0.384524154642484,0,0,3.40483592400691,9.39024833354832,EIF4A1;RPL10;EIF3I
Glycolipid Biosynthetic Process (GO:0009247),2/43,0.0664111832568,0.384524154642484,0,0,4.96932361076188,13.4762580831859,PIGQ;TP53INP2
ADP Transport (GO:0015866),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,SLC25A5
Regulation Of Chaperone-Mediated Autophagy (GO:1904714),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,PLK3
Regulation Of Chromosome Condensation (GO:0060623),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,NCAPH2
Regulation Of Cytoplasmic Translational Elongation (GO:1900247),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,DPH7
Negative Regulation Of Inflammatory Response To Wounding (GO:0106015),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,SIGLEC10
IMP Biosynthetic Process (GO:0006188),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,AMPD2
Regulation Of Heterochromatin Formation (GO:0031445),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,SAMD1
UV Protection (GO:0009650),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,GPX1
Regulation Of Mammary Gland Epithelial Cell Proliferation (GO:0033599),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,GPX1
Anterograde Axonal Protein Transport (GO:0099641),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,MAPK8IP3
Regulation Of Mitophagy (GO:1901524),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,SLC25A5
Axo-Dendritic Protein Transport (GO:0099640),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,MAPK8IP3
Nonribosomal Peptide Biosynthetic Process (GO:0019184),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,HAGH
Blood Coagulation, Intrinsic Pathway (GO:0007597),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,F12
Regulation Of Response To Wounding (GO:1903034),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,PLAU
Positive Regulation Of Astrocyte Differentiation (GO:0048711),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,HES1
Dendritic Spine Maintenance (GO:0097062),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,PICK1
Positive Regulation Of Chromosome Condensation (GO:1905821),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,NCAPH2
Establishment Of Planar Polarity (GO:0001736),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,FUZ
Foam Cell Differentiation (GO:0090077),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,SAMD1
Glutathione Catabolic Process (GO:0006751),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,GGT5
Glycoside Catabolic Process (GO:0016139),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,GUSB
Positive Regulation Of Plasminogen Activation (GO:0010756),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,F12
Histone H2A K63-linked Deubiquitination (GO:0070537),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,MPND
Hyperosmotic Response (GO:0006972),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,YBX3
Postsynapse Organization (GO:0099173),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,PICK1
Lipoxygenase Pathway (GO:0019372),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,GPX1
Protein Localization To Presynapse (GO:1905383),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,MAPK8IP3
rRNA Pseudouridine Synthesis (GO:0031118),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,TSR3
Negative Regulation Of Actin Nucleation (GO:0051126),1/7,0.0666252138105392,0.384524154642484,0,0,16.9213675213675,45.8344375768437,PICK1
Protein Modification By Small Protein Conjugation (GO:0032446),7/364,0.0678248085876045,0.384524154642484,0,0,2.01753293910157,5.42883259536157,RNF126;MARCHF2;TRIM28;GPS1;NSMCE1;FBXL15;ZNF598
Monocarboxylic Acid Metabolic Process (GO:0032787),3/97,0.0700890504472112,0.384524154642484,0,0,3.25928784037041,8.66315023731172,GGT5;NAAA;ALKBH7
Hexose Metabolic Process (GO:0019318),2/45,0.0719019560559271,0.384524154642484,0,0,4.73771277871014,12.4718005767175,DCXR;GAA
Zymogen Activation (GO:0031638),2/45,0.0719019560559271,0.384524154642484,0,0,4.73771277871014,12.4718005767175,PLAU;F12
Intracellular Protein Transmembrane Transport (GO:0065002),2/46,0.0747008204655017,0.384524154642484,0,0,4.62980318650422,12.0109326756729,HSPA5;DNLZ
Protein Sumoylation (GO:0016925),2/46,0.0747008204655017,0.384524154642484,0,0,4.62980318650422,12.0109326756729,TRIM28;NSMCE1
Protein Complex Oligomerization (GO:0051259),3/100,0.0752869536183819,0.384524154642484,0,0,3.1580043801079,8.16801543267454,FKRP;PRMT1;SAMD1
Negative Regulation Of Glial Cell Differentiation (GO:0045686),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,HES1
Regulation Of Endothelial Cell Differentiation (GO:0045601),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,NOTCH4
L-arginine Transmembrane Transport (GO:1903826),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,SLC7A7
N-acylphosphatidylethanolamine Metabolic Process (GO:0070292),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,NAAA
Regulation Of Glial Cell Proliferation (GO:0060251),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,HES1
Regulation Of Lysosomal Protein Catabolic Process (GO:1905165),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,MARCHF2
Neuronal Ion Channel Clustering (GO:0045161),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,PICK1
Basic Amino Acid Transmembrane Transport (GO:1990822),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,SLC7A7
Plasminogen Activation (GO:0031639),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,PLAU
Regulation Of Urine Volume (GO:0035809),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,HYAL2
Response To Misfolded Protein (GO:0051788),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,F12
Positive Regulation Of Centriole Replication (GO:0046601),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,PPP1R35
Ubiquitin-Dependent Protein Catabolic Process Via The C-end Degron Rule Pathway (GO:0140627),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,KLHDC3
Vascular Associated Smooth Muscle Cell Differentiation (GO:0035886),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,HES1
Hyaluronan Catabolic Process (GO:0030214),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,HYAL2
Monocyte Activation (GO:0042117),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,HYAL2
Regulation Of RNA Biosynthetic Process (GO:2001141),1/8,0.0757754712529478,0.384524154642484,0,0,14.5032967032967,37.4182246664331,CXCL8
rRNA Processing (GO:0006364),3/101,0.0770566272796248,0.384524154642484,0,0,3.12562123294914,8.01163831655979,DDX27;SPPL2B;TSR3
Positive Regulation Of TOR Signaling (GO:0032008),2/47,0.0775340657337229,0.384524154642484,0,0,4.52668957617411,11.5749167233695,SESN2;GPR137
Epithelial To Mesenchymal Transition (GO:0001837),2/47,0.0775340657337229,0.384524154642484,0,0,4.52668957617411,11.5749167233695,TRIM28;NOTCH4
Protein Monoubiquitination (GO:0006513),2/47,0.0775340657337229,0.384524154642484,0,0,4.52668957617411,11.5749167233695,RNF126;ZNF598
Cytoplasmic Microtubule Organization (GO:0031122),2/48,0.080400757373626,0.384524154642484,0,0,4.42805916629314,11.1619490336624,PLK3;STMN3
Unsaturated Fatty Acid Metabolic Process (GO:0033559),2/49,0.0832999757450453,0.384524154642484,0,0,4.33362579513051,10.7703906149609,FAAH;GPX1
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:0008630),2/49,0.0832999757450453,0.384524154642484,0,0,4.33362579513051,10.7703906149609,DDIT4;CDIP1
Regulation Of Endoplasmic Reticulum Unfolded Protein Response (GO:1900101),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,HSPA5
Golgi Inheritance (GO:0048313),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,PLK3
IMP Metabolic Process (GO:0046040),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,AMPD2
Negative Regulation Of Necroptotic Process (GO:0060546),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,YBX3
Regulation Of Inflammatory Response To Wounding (GO:0106014),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,SIGLEC10
T-helper 1 Type Immune Response (GO:0042088),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,IL18BP
Negative Regulation Of Protein Localization To Cell Surface (GO:2000009),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,TAX1BP3
Negative Regulation Of Transcription By RNA Polymerase I (GO:0016479),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,MAF1
Aminoglycan Metabolic Process (GO:0006022),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,CLN6
Neuron Projection Regeneration (GO:0031102),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,MAPK8IP3
Axon Regeneration (GO:0031103),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,MAPK8IP3
Regulation Of Protein Localization To Centrosome (GO:1904779),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,PARD6A
Peptidyl-Amino Acid Modification (GO:0018193),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,TTLL4
Regulation Of Tau-Protein Kinase Activity (GO:1902947),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,NAB2
Cellular Response To Oxygen Levels (GO:0071453),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,PICK1
Leucine Transport (GO:0015820),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,SLC7A7
Leukotriene D4 Biosynthetic Process (GO:1901750),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,GGT5
Regulation Of PERK-mediated Unfolded Protein Response (GO:1903897),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,HSPA5
Negative Regulation Of Bone Resorption (GO:0045779),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,GPR137
Negative Regulation Of Cell-Cell Adhesion Mediated By Cadherin (GO:2000048),1/9,0.0848364792337448,0.384524154642484,0,0,12.6897435897436,31.3059736746355,NOTCH4
Regulation Of TORC1 Signaling (GO:1903432),2/50,0.0862308158063644,0.384524154642484,0,0,4.24312714776632,10.3987491221252,SESN2;GPR137
Response To Tumor Necrosis Factor (GO:0034612),3/108,0.0899453932362593,0.384524154642484,0,0,2.91621021465581,7.02384550397509,CXCL8;HYAL2;YBX3
Positive Regulation Of Translation (GO:0045727),3/108,0.0899453932362593,0.384524154642484,0,0,2.91621021465581,7.02384550397509,PRMT1;EIF4A3;YBX3
Arachidonic Acid Metabolic Process (GO:0019369),2/52,0.0921838131138757,0.384524154642484,0,0,4.07298969072165,9.70988819237823,FAAH;GPX1
Icosanoid Metabolic Process (GO:0006690),2/52,0.0921838131138757,0.384524154642484,0,0,4.07298969072165,9.70988819237823,FAAH;GPX1
Negative Regulation Of Inclusion Body Assembly (GO:0090084),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,DNAJB2
Regulation Of Glycoprotein Biosynthetic Process (GO:0010559),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,NECAB2
Regulation Of Inclusion Body Assembly (GO:0090083),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,DNAJB2
Negative Regulation Of Programmed Necrotic Cell Death (GO:0062099),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,YBX3
Negative Regulation Of Sprouting Angiogenesis (GO:1903671),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,EPN2
Negative Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030948),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,EPN2
Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Nonsense-Mediated Decay (GO:2000622),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,EIF4A3
Branched-Chain Amino Acid Transport (GO:0015803),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,SLC7A7
Regulation Of Protein Localization To Cajal Body (GO:1904869),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,MEPCE
Cellular Response To Leucine (GO:0071233),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,SESN2
Positive Regulation Of DNA Methylation-Dependent Heterochromatin Formation (GO:0090309),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,TRIM28
Positive Regulation Of Autophagy Of Mitochondrion (GO:1903599),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,SLC25A5
Response To Leucine (GO:0043201),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,SESN2
Diol Metabolic Process (GO:0034311),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,NAAA
Heparan Sulfate Proteoglycan Biosynthetic Process, Enzymatic Modification (GO:0015015),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,HS6ST1
Positive Regulation Of Protein Localization To Cajal Body (GO:1904871),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,MEPCE
Induction Of Positive Chemotaxis (GO:0050930),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,CXCL8
Positive Regulation Of Transcription From RNA Polymerase II Promoter In Response To Endoplasmic Reticulum Stress (GO:1990440),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,HSPA5
Protein Deneddylation (GO:0000338),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,GPS1
Protein Kinase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007205),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,PICK1
Protein Prenylation (GO:0018342),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,RCE1
Midbrain Dopaminergic Neuron Differentiation (GO:1904948),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,NR4A2
Mitotic DNA Replication (GO:1902969),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,RECQL5
Mitotic G1/S Transition Checkpoint Signaling (GO:0044819),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,PLK3
Regulation Of Amyloid Precursor Protein Biosynthetic Process (GO:0042984),1/10,0.0938091036064344,0.384524154642484,0,0,11.2792022792023,26.6921574611874,NECAB2
NADH Dehydrogenase Complex Assembly (GO:0010257),2/53,0.0952042318179649,0.384524154642484,0,0,3.99292500505357,9.39028506107761,NDUFA6;NDUFS7
Regulation Of Macromolecule Biosynthetic Process (GO:0010556),2/53,0.0952042318179649,0.384524154642484,0,0,3.99292500505357,9.39028506107761,RPL10;ELP5
Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046425),2/53,0.0952042318179649,0.384524154642484,0,0,3.99292500505357,9.39028506107761,TP53INP2;HES1
Proton Motive Force-Driven Mitochondrial ATP Synthesis (GO:0042776),2/53,0.0952042318179649,0.384524154642484,0,0,3.99292500505357,9.39028506107761,NDUFA6;NDUFS7
Mitochondrial Respiratory Chain Complex I Assembly (GO:0032981),2/53,0.0952042318179649,0.384524154642484,0,0,3.99292500505357,9.39028506107761,NDUFA6;NDUFS7
Protein K63-linked Ubiquitination (GO:0070534),2/54,0.0982527947854608,0.384524154642484,0,0,3.91593973037272,9.08580872067721,RNF126;ZNF598
Mesenchymal Cell Differentiation (GO:0048762),2/54,0.0982527947854608,0.384524154642484,0,0,3.91593973037272,9.08580872067721,TRIM28;NOTCH4
Negative Regulation Of TOR Signaling (GO:0032007),2/54,0.0982527947854608,0.384524154642484,0,0,3.91593973037272,9.08580872067721,SESN2;DDIT4
Neuron Migration (GO:0001764),2/55,0.101328667347076,0.384524154642484,0,0,3.84185956039681,8.79549915814657,NR4A2;DDIT4
Cellular Response To Fibroblast Growth Factor Stimulus (GO:0044344),2/55,0.101328667347076,0.384524154642484,0,0,3.84185956039681,8.79549915814657,CXCL8;HYAL2
Response To Endoplasmic Reticulum Stress (GO:0034976),3/114,0.101658470829428,0.384524154642484,0,0,2.75773701162302,6.30456298895236,CXCL8;HSPA5;DNAJB9
AMP Metabolic Process (GO:0046033),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,AMPD2
Negative Regulation Of Fibrinolysis (GO:0051918),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,PLAU
Brain Morphogenesis (GO:0048854),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,VPS51
Pentose-Phosphate Shunt (GO:0006098),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,RBKS
Cellular Response To UV-B (GO:0071493),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,HYAL2
Cellular Response To Nitrogen Levels (GO:0043562),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,MAP1LC3A
Cellular Response To Nitrogen Starvation (GO:0006995),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,MAP1LC3A
Positive Regulation Of Coagulation (GO:0050820),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,F12
Sphingoid Metabolic Process (GO:0046519),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,NAAA
Positive Regulation Of Hemostasis (GO:1900048),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,F12
Histone H2A Ubiquitination (GO:0033522),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,RING1
Leukotriene D4 Metabolic Process (GO:1901748),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,GGT5
Maintenance Of Protein Localization In Endoplasmic Reticulum (GO:0035437),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,HSPA5
Protein Polyglutamylation (GO:0018095),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,TTLL4
Purine Ribonucleoside Monophosphate Biosynthetic Process (GO:0009168),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,AMPD2
Purine Ribonucleoside Monophosphate Metabolic Process (GO:0009167),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,AMPD2
Regulation Of Astrocyte Differentiation (GO:0048710),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,HES1
Negative Regulation Of Bone Remodeling (GO:0046851),1/11,0.102694201942671,0.384524154642484,0,0,10.1507692307692,23.1031469108803,GPR137
Positive Regulation Of Cellular Metabolic Process (GO:0031325),2/56,0.104431028343848,0.389562937192782,0,0,3.77052310042001,8.51847302716804,CXCL8;DCXR
Post-Transcriptional Regulation Of Gene Expression (GO:0010608),2/57,0.107559069942801,0.394181224773278,0,0,3.70178069353327,8.25391628885381,RPL10;ELP5
Regulation Of Chromosome Separation (GO:1905818),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,NCAPH2
NADPH Regeneration (GO:0006740),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,RBKS
Negative Regulation Of Stem Cell Differentiation (GO:2000737),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,HES1
Cell-Cell Junction Maintenance (GO:0045217),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,PARD6A
Cellular Component Maintenance (GO:0043954),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,PICK1
Cellular Response To Leucine Starvation (GO:1990253),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,SESN2
Fibrinolysis (GO:0042730),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,PLAU
Granulocyte Activation (GO:0036230),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,CXCL8
Positive Regulation Of Protein Export From Nucleus (GO:0046827),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,EMD
Histone Monoubiquitination (GO:0010390),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,RING1
Mitochondrial Transcription (GO:0006390),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,POLRMT
Morphogenesis Of A Polarized Epithelium (GO:0001738),1/12,0.111492623568794,0.394181224773278,0,0,9.22750582750583,20.243273186403,FUZ
Cellular Response To Tumor Necrosis Factor (GO:0071356),3/119,0.111858314314004,0.394181224773278,0,0,2.63819903519743,5.7790337110824,CXCL8;HYAL2;YBX3
DNA-templated Transcription Initiation (GO:0006352),2/59,0.113889029071634,0.394181224773278,0,0,3.57153192258998,7.75926286883782,TAF13;POLRMT
Aerobic Respiration (GO:0009060),2/59,0.113889029071634,0.394181224773278,0,0,3.57153192258998,7.75926286883782,NDUFA6;NDUFS7
Glucose Metabolic Process (GO:0006006),2/59,0.113889029071634,0.394181224773278,0,0,3.57153192258998,7.75926286883782,DCXR;GAA
Defense Response To Virus (GO:0051607),4/189,0.11538191920377,0.394181224773278,0,0,2.20934684684685,4.77110134331578,MARCHF2;TRIM28;DDIT4;MAP3K14
Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),2/60,0.117089395941053,0.394181224773278,0,0,3.50977603981514,7.52782931016347,HYAL2;G0S2
Proton Motive Force-Driven ATP Synthesis (GO:0015986),2/60,0.117089395941053,0.394181224773278,0,0,3.50977603981514,7.52782931016347,NDUFA6;NDUFS7
ATP Transport (GO:0015867),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,SLC25A5
Negative Regulation Of Fibroblast Growth Factor Receptor Signaling Pathway (GO:0040037),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,FUZ
Negative Regulation Of Receptor Internalization (GO:0002091),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,NECAB2
Branching Involved In Blood Vessel Morphogenesis (GO:0001569),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,NOTCH4
Positive Regulation Of Chromosome Separation (GO:1905820),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,NCAPH2
Endonucleolytic Cleavage Of Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,TBL3
Spliceosomal tri-snRNP Complex Assembly (GO:0000244),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,TSSC4
Positive Regulation Of Heterochromatin Formation (GO:0031453),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,TRIM28
Thymus Development (GO:0048538),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,HES1
Heparan Sulfate Proteoglycan Metabolic Process (GO:0030201),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,HS6ST1
Lipid Oxidation (GO:0034440),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,SAMD1
Membrane Protein Intracellular Domain Proteolysis (GO:0031293),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,SPPL2B
Monoacylglycerol Metabolic Process (GO:0046462),1/13,0.120205209634927,0.394181224773278,0,0,8.45811965811966,17.9189909854753,FAAH
Neuron Projection Development (GO:0031175),4/192,0.120310717249397,0.394181224773278,0,0,2.17375886524823,4.60332039647484,BLOC1S4;PRMT1;STMN3;MAPK8IP3
Autophagosome Organization (GO:1905037),2/61,0.120312341697868,0.394181224773278,0,0,3.45011357679539,7.30618155989194,MAP1LC3A;TP53INP2
Fatty Acid Catabolic Process (GO:0009062),2/61,0.120312341697868,0.394181224773278,0,0,3.45011357679539,7.30618155989194,FAAH;ECI1
Positive Regulation Of Organelle Assembly (GO:1902117),2/61,0.120312341697868,0.394181224773278,0,0,3.45011357679539,7.30618155989194,PPP1R35;FUZ
Negative Regulation Of Signal Transduction (GO:0009968),5/267,0.122620067656031,0.400424876673466,0,0,1.95255984972623,4.0977682065066,NR4A2;CXCL8;TAX1BP3;ZNF653;EPN2
Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),2/62,0.123557122443059,0.400856332095396,0,0,3.39243986254296,7.09376714153088,HYAL2;G0S2
Protein Lipidation (GO:0006497),2/62,0.123557122443059,0.400856332095396,0,0,3.39243986254296,7.09376714153088,PIGQ;TP53INP2
Oxidative Phosphorylation (GO:0006119),2/63,0.126823006590005,0.402249097179936,0,0,3.33665708974142,6.8900728115603,NDUFA6;NDUFS7
Blood Coagulation, Fibrin Clot Formation (GO:0072378),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,F12
Positive Regulation Of Cytoplasmic Translation (GO:2000767),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,YBX3
Endoderm Development (GO:0007492),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,DUSP2
Positive Regulation Of Histone Acetylation (GO:0035066),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,DDX21
Striated Muscle Tissue Development (GO:0014706),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,PRMT1
Establishment Of Spindle Localization (GO:0051293),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,LLGL1
Formation Of Cytoplasmic Translation Initiation Complex (GO:0001732),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,EIF3I
Histone H2A Monoubiquitination (GO:0035518),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,RING1
Hyaluronan Metabolic Process (GO:0030212),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,HYAL2
Primary Alcohol Metabolic Process (GO:0034308),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,NAAA
Protein Activation Cascade (GO:0072376),1/14,0.128832793173092,0.402249097179936,0,0,7.80710059171598,15.9986219760336,F12
Positive Regulation Of Macroautophagy (GO:0016239),2/64,0.130109274611184,0.404965117227312,0,0,3.28267376122381,6.69462120997582,SESN2;SLC25A5
Autophagosome Assembly (GO:0000045),2/65,0.13341521896014,0.410890974370852,0,0,3.23040418916708,6.50696783974361,MAP1LC3A;TP53INP2
Regulation Of Translation (GO:0006417),4/202,0.137375408474584,0.410890974370852,0,0,2.06292087542088,4.09497610763163,RPL10;PRMT1;EIF4A3;ELP5
Negative Regulation Of Epithelial Cell Differentiation (GO:0030857),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,NOTCH4
Negative Regulation Of Protein Processing (GO:0010955),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,PLAU
Negative Regulation Of Synaptic Transmission (GO:0050805),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,PICK1
Anterograde Synaptic Vesicle Transport (GO:0048490),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,BLOC1S4
Neurotrophin Signaling Pathway (GO:0038179),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,DDIT4
Synaptic Vesicle Transport Along Microtubule (GO:0099517),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,BLOC1S4
tRNA Wobble Base Modification (GO:0002097),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,ELP5
tRNA Wobble Uridine Modification (GO:0002098),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,ELP5
Positive Regulation Of Transcription By RNA Polymerase III (GO:0045945),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,DDX21
Mitotic Chromosome Condensation (GO:0007076),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,NCAPH2
Regulation Of Rac Protein Signal Transduction (GO:0035020),1/15,0.137376199262544,0.410890974370852,0,0,7.24908424908425,14.3896651942717,STMN3
Plasma Membrane Bounded Cell Projection Organization (GO:0120036),3/132,0.14006662004013,0.415024220816721,0,0,2.37076756235691,4.66006870479697,BLOC1S4;PRMT1;STMN3
Extrinsic Apoptotic Signaling Pathway (GO:0097191),2/67,0.140083365158009,0.415024220816721,0,0,3.13068992862807,6.15342605523535,SIVA1;G0S2
B Cell Differentiation (GO:0030183),2/68,0.143444210146463,0.415024220816721,0,0,3.08309903155264,5.98678975210589,DNAJB9;SLC25A5
Negative Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090201),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,GPX1
Neuron Projection Organization (GO:0106027),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,PICK1
Pharyngeal System Development (GO:0060037),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,HES1
Response To UV-B (GO:0010224),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,HYAL2
Tail-Anchored Membrane Protein Insertion Into ER Membrane (GO:0071816),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,UBL4A
Vasculature Development (GO:0001944),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,NOTCH4
Heart Process (GO:0003015),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,GPX1
Positive Regulation Of Positive Chemotaxis (GO:0050927),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,CXCL8
Protein O-linked Mannosylation (GO:0035269),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,FKRP
Protein Localization To Endoplasmic Reticulum (GO:0070972),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,HSPA5
Negative Regulation Of RNA Biosynthetic Process (GO:1902679),1/16,0.145836244922083,0.415024220816721,0,0,6.76547008547009,13.0253626592129,ZNF653
Regulation Of Notch Signaling Pathway (GO:0008593),2/70,0.150216136735296,0.415024220816721,0,0,2.99211643420255,5.67209561242098,LLGL1;EPN2
Regulation Of Cilium Assembly (GO:1902017),2/71,0.153625928830498,0.415024220816721,0,0,2.94860301807859,5.52342538686134,PPP1R35;FUZ
Negative Regulation Of Fibroblast Proliferation (GO:0048147),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,EMD
DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Cell Cycle Arrest (GO:0006977),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,PLK3
NAD Biosynthetic Process (GO:0009435),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,NAPRT
Neural Tube Development (GO:0021915),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,FUZ
Neuron Maturation (GO:0042551),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,PICK1
Nuclear Envelope Organization (GO:0006998),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,EMD
Regulation Of Single Stranded Viral RNA Replication Via Double Stranded DNA Intermediate (GO:0045091),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,CXCL8
Polyol Metabolic Process (GO:0019751),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,IMPA2
Embryonic Heart Tube Development (GO:0035050),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,HES1
Positive Regulation Of Glial Cell Differentiation (GO:0045687),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,HES1
Positive Regulation Of Peptidyl-Lysine Acetylation (GO:2000758),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,DDX21
Positive Regulation Of Transcription From RNA Polymerase II Promoter In Response To Stress (GO:0036003),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,HSPA5
Microtubule Depolymerization (GO:0007019),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,STMN3
rRNA Modification (GO:0000154),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,TSR3
Motile Cilium Assembly (GO:0044458),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,ENKD1
ncRNA Metabolic Process (GO:0034660),1/17,0.154213739399279,0.415024220816721,0,0,6.34230769230769,11.8564097052599,MEPCE
Protein Targeting To Membrane (GO:0006612),2/72,0.157050765329921,0.415024220816721,0,0,2.90633284241532,5.38016319191888,UBL4A;YIF1B
Negative Regulation Of Cellular Process (GO:0048523),8/537,0.158458830930341,0.415024220816721,0,0,1.55049672203676,2.85641880617884,KLF10;DNAJB2;CXCL8;HYAL2;NOTCH4;SESN2;OSGIN1;FUZ
Negative Regulation Of Wnt Signaling Pathway (GO:0030178),3/140,0.158496344787173,0.415024220816721,0,0,2.23142089936084,4.11033028664422,FUZ;TAX1BP3;EMD
Monocarboxylic Acid Transport (GO:0015718),2/73,0.160490028468414,0.415024220816721,0,0,2.86525337592566,5.24204828805026,SLC5A6;SLC10A3
3'-UTR-mediated mRNA Stabilization (GO:0070935),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,YBX3
Regulation Of Establishment Or Maintenance Of Cell Polarity (GO:0032878),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,LLGL1
Regulation Of Mitochondrial Membrane Permeability (GO:0046902),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,SLC25A5
Neutrophil Activation (GO:0042119),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,CXCL8
Regulation Of Oligodendrocyte Differentiation (GO:0048713),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,HES1
Regulation Of Protein Neddylation (GO:2000434),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,GPS1
Cell Junction Maintenance (GO:0034331),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,PARD6A
Positive Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0045745),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,NECAB2
Renal Absorption (GO:0070293),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,HYAL2
Response To Axon Injury (GO:0048678),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,MAPK8IP3
Positive Regulation Of Chromosome Segregation (GO:0051984),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,NCAPH2
Glucose 6-Phosphate Metabolic Process (GO:0051156),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,RBKS
Positive Regulation Of Neutrophil Chemotaxis (GO:0090023),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,CXCL8
Vesicle Transport Along Actin Filament (GO:0030050),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,MYO7B
Lysosomal Lumen Acidification (GO:0007042),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,CLN6
Protein Autoprocessing (GO:0016540),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,F12
Maintenance Of Gastrointestinal Epithelium (GO:0030277),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,STRAP
Maintenance Of Protein Localization In Organelle (GO:0072595),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,HSPA5
Protein Import Into Mitochondrial Matrix (GO:0030150),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,DNLZ
Negative Regulation Of ERBB Signaling Pathway (GO:1901185),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,RNF126
Regulation Of Cell-Cell Adhesion Mediated By Cadherin (GO:2000047),1/18,0.16250948405474,0.415024220816721,0,0,5.96892911010558,10.8456570983502,NOTCH4
Gland Development (GO:0048732),2/74,0.163943111131262,0.417614676948177,0,0,2.82531500572738,5.10883572460798,NOTCH4;HES1
Gene Expression (GO:0010467),5/296,0.166120722236335,0.417792077254374,0,0,1.7553660423526,3.1509531603786,NXT1;RPL10;ALYREF;EIF4A3;MRPL55
Negative Regulation Of Cell Population Proliferation (GO:0008285),6/379,0.16923999603122,0.417792077254374,0,0,1.64506843516297,2.92236121976376,KLF10;DNAJB2;CXCL8;FUZ;HES1;EMD
Proteasomal Protein Catabolic Process (GO:0010498),4/220,0.170338718034683,0.417792077254374,0,0,1.88927469135802,3.34395265836158,PSMB6;KLHDC3;RNF126;UBXN11
Regulation Of Megakaryocyte Differentiation (GO:0045652),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,PRMT1
Cardiac Ventricle Development (GO:0003231),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,HES1
Regulation Of Smooth Muscle Cell Migration (GO:0014910),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,PLAU
Cellular Response To Misfolded Protein (GO:0071218),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,RNF126
Cortical Actin Cytoskeleton Organization (GO:0030866),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,LLGL1
Dopaminergic Neuron Differentiation (GO:0071542),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,NR4A2
Sphingosine Metabolic Process (GO:0006670),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,NAAA
Epithelial Structure Maintenance (GO:0010669),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,STRAP
Ganglioside Metabolic Process (GO:0001573),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,CLN6
Glycogen Metabolic Process (GO:0005977),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,GAA
Leukotriene Biosynthetic Process (GO:0019370),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,GGT5
Receptor Clustering (GO:0043113),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,PICK1
Regulation Of Acute Inflammatory Response (GO:0002673),1/19,0.170724272532661,0.417792077254374,0,0,5.63703703703704,9.96462117785777,F12
Regulation Of Transcription Elongation By RNA Polymerase II (GO:0034243),2/77,0.174379359532265,0.422140889335337,0,0,2.71189003436426,4.7363759478002,RECQL5;NELFA
Embryonic Organ Development (GO:0048568),2/77,0.174379359532265,0.422140889335337,0,0,2.71189003436426,4.7363759478002,CXCL8;RPL10
DNA Damage Response (GO:0006974),6/384,0.176368915671015,0.422140889335337,0,0,1.62289055973267,2.81600296666863,PLK3;RECQL5;TRIM28;NSMCE1;ZNF668;ALKBH7
Cellular Response To Nutrient Levels (GO:0031669),2/78,0.177881854360062,0.422140889335337,0,0,2.67607162235486,4.62060076844206,KLF10;MAP1LC3A
Long-Chain Fatty Acid Metabolic Process (GO:0001676),2/78,0.177881854360062,0.422140889335337,0,0,2.67607162235486,4.62060076844206,FAAH;GPX1
DNA Methylation (GO:0006306),1/20,0.178858890862964,0.422140889335337,0,0,5.34008097165992,9.19112363627508,PICK1
DNA Unwinding Involved In DNA Replication (GO:0006268),1/20,0.178858890862964,0.422140889335337,0,0,5.34008097165992,9.19112363627508,RECQL5
Regulation Of Fibroblast Migration (GO:0010762),1/20,0.178858890862964,0.422140889335337,0,0,5.34008097165992,9.19112363627508,HYAL2
Actin Filament-Based Transport (GO:0099515),1/20,0.178858890862964,0.422140889335337,0,0,5.34008097165992,9.19112363627508,MYO7B
Adenine Nucleotide Transport (GO:0051503),1/20,0.178858890862964,0.422140889335337,0,0,5.34008097165992,9.19112363627508,SLC25A5
Regulation Of Necroptotic Process (GO:0060544),1/20,0.178858890862964,0.422140889335337,0,0,5.34008097165992,9.19112363627508,YBX3
Hydrogen Peroxide Catabolic Process (GO:0042744),1/20,0.178858890862964,0.422140889335337,0,0,5.34008097165992,9.19112363627508,GPX1
Positive Regulation Of Protein Processing (GO:0010954),1/20,0.178858890862964,0.422140889335337,0,0,5.34008097165992,9.19112363627508,F12
Mitochondrial RNA Metabolic Process (GO:0000959),1/20,0.178858890862964,0.422140889335337,0,0,5.34008097165992,9.19112363627508,POLRMT
Monocarboxylic Acid Catabolic Process (GO:0072329),1/20,0.178858890862964,0.422140889335337,0,0,5.34008097165992,9.19112363627508,FAAH
Negative Regulation Of Cellular Component Organization (GO:0051129),2/79,0.181395286011357,0.427115141530289,0,0,2.64118355870933,4.50870298836203,DNAJB2;HSPA5
Regulation Of Cell Growth (GO:0001558),4/227,0.183848816646685,0.431871276839855,0,0,1.82931614349776,3.09820575146291,DNAJB2;HYAL2;SESN2;OSGIN1
Negative Regulation Of Osteoclast Differentiation (GO:0045671),1/21,0.186914117406554,0.432945257992856,0,0,5.07282051282051,8.50765788550343,GPR137
snRNA Metabolic Process (GO:0016073),1/21,0.186914117406554,0.432945257992856,0,0,5.07282051282051,8.50765788550343,MEPCE
Positive Regulation Of Granulocyte Chemotaxis (GO:0071624),1/21,0.186914117406554,0.432945257992856,0,0,5.07282051282051,8.50765788550343,CXCL8
Sulfur Compound Transport (GO:0072348),1/21,0.186914117406554,0.432945257992856,0,0,5.07282051282051,8.50765788550343,SLC5A6
Protein Mannosylation (GO:0035268),1/21,0.186914117406554,0.432945257992856,0,0,5.07282051282051,8.50765788550343,FKRP
Modulation By Symbiont Of Entry Into Host (GO:0052372),1/21,0.186914117406554,0.432945257992856,0,0,5.07282051282051,8.50765788550343,CXCL8
Cellular Response To Interleukin-1 (GO:0071347),2/81,0.188452781873385,0.435496451846617,0,0,2.57405715777111,4.29586406184923,CXCL8;HYAL2
Cellular Response To Growth Factor Stimulus (GO:0071363),3/155,0.194848443628231,0.4362382579564,0,0,2.00968093809654,3.28689996553515,CXCL8;HYAL2;EMD
Ribosome Biogenesis (GO:0042254),3/155,0.194848443628231,0.4362382579564,0,0,2.00968093809654,3.28689996553515,TBL3;DDX27;SPPL2B
Negative Regulation Of Myeloid Cell Differentiation (GO:0045638),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,PRMT1
Regulation Of Histone Acetylation (GO:0035065),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,DDX21
Regulation Of Protein Export From Nucleus (GO:0046825),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,EMD
Peptidyl-Glutamic Acid Modification (GO:0018200),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,TTLL4
Regulation Of Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0030947),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,EPN2
Ribosomal Large Subunit Assembly (GO:0000027),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,RPL10
Positive Regulation Of Receptor Internalization (GO:0002092),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,PICK1
Mammary Gland Development (GO:0030879),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,NOTCH4
Membrane Protein Ectodomain Proteolysis (GO:0006509),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,SPPL2B
Protein Neddylation (GO:0045116),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,GPS1
Negative Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0045744),1/22,0.194890723063668,0.4362382579564,0,0,4.83101343101343,7.90023487419645,CXCL8
Vesicle-Mediated Transport To The Plasma Membrane (GO:0098876),2/83,0.195547586001361,0.4362382579564,0,0,2.51024564082983,4.09659919544826,VPS51;LLGL1
Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),2/83,0.195547586001361,0.4362382579564,0,0,2.51024564082983,4.09659919544826,DNAJB2;PLK3
Peptide Biosynthetic Process (GO:0043043),3/158,0.202355337230815,0.4362382579564,0,0,1.97048303526659,3.14829992254815,GGT5;RPL10;MRPL55
Positive Regulation Of Amide Metabolic Process (GO:0034250),2/85,0.202675586190041,0.4362382579564,0,0,2.44950937771705,3.90978114971642,PRMT1;EIF4A3
Response To Interleukin-1 (GO:0070555),2/85,0.202675586190041,0.4362382579564,0,0,2.44950937771705,3.90978114971642,CXCL8;HYAL2
Negative Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042059),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,RNF126
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902042),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,GPX1
Negative Regulation Of Neuron Differentiation (GO:0045665),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,HES1
Negative Regulation Of Protein Tyrosine Kinase Activity (GO:0061099),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,HYAL2
Adaptive Immune Response Based On Somatic Recombination Of Immune Receptors Built From Immunoglobulin Superfamily Domains (GO:0002460),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,IL18BP
Artery Development (GO:0060840),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,HES1
Bile Acid And Bile Salt Transport (GO:0015721),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,SLC10A3
Cellular Lipid Catabolic Process (GO:0044242),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,FAAH
Rescue Of Stalled Ribosome (GO:0072344),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,ZNF598
Glial Cell Development (GO:0021782),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,PICK1
Positive Regulation Of Neutrophil Migration (GO:1902624),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,CXCL8
Heparan Sulfate Proteoglycan Biosynthetic Process (GO:0015012),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,HS6ST1
Protein Alkylation (GO:0008213),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,PRMT1
Protein Targeting To ER (GO:0045047),1/23,0.202789471319089,0.4362382579564,0,0,4.61118881118881,7.35755257669388,UBL4A
Negative Regulation Of DNA-templated Transcription (GO:0045892),13/1025,0.206781373746881,0.443866914335978,0,0,1.31912136331238,2.07905822299423,KLF10;PLK3;RING1;RPL10;NOTCH4;NAB2;NR4A2;TRIM28;HES1;SAMD1;MAF1;GZF1;MXD4
Regulation Of Cytoplasmic Translation (GO:2000765),1/24,0.210611118171142,0.4444251561408,0,0,4.41047937569677,6.87038846897868,YBX3
Acylglycerol Catabolic Process (GO:0046464),1/24,0.210611118171142,0.4444251561408,0,0,4.41047937569677,6.87038846897868,FAAH
Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903050),1/24,0.210611118171142,0.4444251561408,0,0,4.41047937569677,6.87038846897868,GPX1
Regulation Of Supramolecular Fiber Organization (GO:1902903),1/24,0.210611118171142,0.4444251561408,0,0,4.41047937569677,6.87038846897868,GPX1
Positive Regulation Of BMP Signaling Pathway (GO:0030513),1/24,0.210611118171142,0.4444251561408,0,0,4.41047937569677,6.87038846897868,FBXL15
Positive Regulation Of p38MAPK Cascade (GO:1900745),1/24,0.210611118171142,0.4444251561408,0,0,4.41047937569677,6.87038846897868,PRMT1
Protein Kinase B Signaling (GO:0043491),1/24,0.210611118171142,0.4444251561408,0,0,4.41047937569677,6.87038846897868,PLK3
Regulation Of Actin Nucleation (GO:0051125),1/24,0.210611118171142,0.4444251561408,0,0,4.41047937569677,6.87038846897868,PICK1
Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),2/88,0.213421188625607,0.44940275659853,0,0,2.36370175017981,3.65070817181103,PPP1R35;FUZ
Cellular Response To Chemical Stress (GO:0062197),2/89,0.217015445158453,0.452147581676717,0,0,2.33641426709326,3.56954276475062,GPX1;SESN2
Negative Regulation Of Response To Wounding (GO:1903035),1/25,0.218356412436246,0.452147581676717,0,0,4.22649572649573,6.43114845656813,SIGLEC10
Regulation Of Lysosomal Lumen pH (GO:0035751),1/25,0.218356412436246,0.452147581676717,0,0,4.22649572649573,6.43114845656813,CLN6
Regulation Of Neutrophil Chemotaxis (GO:0090022),1/25,0.218356412436246,0.452147581676717,0,0,4.22649572649573,6.43114845656813,CXCL8
Regulation Of Protein Processing (GO:0070613),1/25,0.218356412436246,0.452147581676717,0,0,4.22649572649573,6.43114845656813,PLAU
Phosphatidylethanolamine Metabolic Process (GO:0046337),1/25,0.218356412436246,0.452147581676717,0,0,4.22649572649573,6.43114845656813,NAAA
Mitotic Cell Cycle Checkpoint Signaling (GO:0007093),1/25,0.218356412436246,0.452147581676717,0,0,4.22649572649573,6.43114845656813,PLK3
Negative Regulation Of TORC1 Signaling (GO:1904262),1/25,0.218356412436246,0.452147581676717,0,0,4.22649572649573,6.43114845656813,SESN2
Regulation Of Cell Population Proliferation (GO:0042127),10/766,0.220111090886324,0.454835366229832,0,0,1.35461113955738,2.05037044346682,KLF10;DNAJB2;RNF126;CXCL8;PRMT1;OSGIN1;FUZ;HES1;SLC25A5;BRICD5
Mitochondrial Respiratory Chain Complex Assembly (GO:0033108),2/90,0.220615127498134,0.454933057946463,0,0,2.30974695407685,3.49080279910275,NDUFA6;NDUFS7
Proteolysis (GO:0006508),5/330,0.223614952511349,0.45756502292886,0,0,1.56898912605719,2.35007846215512,GGT5;PLAU;CLPP;F12;SPPL2B
Lymphocyte Differentiation (GO:0030098),2/91,0.224219786833467,0.45756502292886,0,0,2.28367890652149,3.41439345671968,DNAJB9;SLC25A5
rRNA Metabolic Process (GO:0016072),2/91,0.224219786833467,0.45756502292886,0,0,2.28367890652149,3.41439345671968,DDX27;SPPL2B
Regulation Of Myeloid Cell Differentiation (GO:0045637),1/26,0.226026095663654,0.45756502292886,0,0,4.05723076923077,6.03352742805854,PRMT1
Nuclear Membrane Organization (GO:0071763),1/26,0.226026095663654,0.45756502292886,0,0,4.05723076923077,6.03352742805854,EMD
Dendritic Spine Organization (GO:0097061),1/26,0.226026095663654,0.45756502292886,0,0,4.05723076923077,6.03352742805854,PICK1
Positive Regulation Of Erythrocyte Differentiation (GO:0045648),1/26,0.226026095663654,0.45756502292886,0,0,4.05723076923077,6.03352742805854,PRMT1
Meiosis I (GO:0007127),1/26,0.226026095663654,0.45756502292886,0,0,4.05723076923077,6.03352742805854,MEI1
Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),1/26,0.226026095663654,0.45756502292886,0,0,4.05723076923077,6.03352742805854,PLK3
B Cell Activation (GO:0042113),2/92,0.227828982704869,0.459360241518109,0,0,2.2581901489118,3.34022455721956,DNAJB9;SLC25A5
Double-Strand Break Repair (GO:0006302),3/168,0.227835300511994,0.459360241518109,0,0,1.85011775788978,2.73656889238102,RECQL5;NSMCE1;MPND
Regulation Of Immunoglobulin Production (GO:0002637),1/27,0.233620902186393,0.462597253633494,0,0,3.90098619329389,5.67225063846001,DNAJB9
Regulation Of Microtubule Polymerization Or Depolymerization (GO:0031110),1/27,0.233620902186393,0.462597253633494,0,0,3.90098619329389,5.67225063846001,STMN3
Cellular Response To Acid Chemical (GO:0071229),1/27,0.233620902186393,0.462597253633494,0,0,3.90098619329389,5.67225063846001,SESN2
Cortical Cytoskeleton Organization (GO:0030865),1/27,0.233620902186393,0.462597253633494,0,0,3.90098619329389,5.67225063846001,LLGL1
Dorsal/Ventral Pattern Formation (GO:0009953),1/27,0.233620902186393,0.462597253633494,0,0,3.90098619329389,5.67225063846001,FBXL15
Positive Regulation Of Mitotic Cell Cycle (GO:0045931),1/27,0.233620902186393,0.462597253633494,0,0,3.90098619329389,5.67225063846001,HES1
Ventricular Septum Morphogenesis (GO:0060412),1/27,0.233620902186393,0.462597253633494,0,0,3.90098619329389,5.67225063846001,HES1
Protein Quality Control For Misfolded Or Incompletely Synthesized Proteins (GO:0006515),1/27,0.233620902186393,0.462597253633494,0,0,3.90098619329389,5.67225063846001,CLPP
Microtubule Polymerization Or Depolymerization (GO:0031109),1/27,0.233620902186393,0.462597253633494,0,0,3.90098619329389,5.67225063846001,STMN3
Peptidyl-Lysine Modification (GO:0018205),2/94,0.235059262065388,0.463602029736884,0,0,2.20887494397131,3.19826894651336,TRIM28;NSMCE1
Retrograde Transport, Endosome To Golgi (GO:0042147),2/94,0.235059262065388,0.463602029736884,0,0,2.20887494397131,3.19826894651336,RNF126;VPS51
Recombinational Repair (GO:0000725),2/95,0.238679504373643,0.464558980744639,0,0,2.18501274803237,3.13032270736128,RECQL5;NSMCE1
Neuron Differentiation (GO:0030182),3/173,0.240798849684339,0.464558980744639,0,0,1.79524535202682,2.55605838058039,NR4A2;DDIT4;HS6ST1
Regulation Of Chromosome Segregation (GO:0051983),1/28,0.241141559282107,0.464558980744639,0,0,3.75631528964862,5.34287444203048,NCAPH2
Nuclear-Transcribed mRNA Catabolic Process, Nonsense-Mediated Decay (GO:0000184),1/28,0.241141559282107,0.464558980744639,0,0,3.75631528964862,5.34287444203048,EIF4A3
Regulation Of Protein Localization To Membrane (GO:1905475),1/28,0.241141559282107,0.464558980744639,0,0,3.75631528964862,5.34287444203048,NECAB2
Regulation Of Protein Transport (GO:0051223),1/28,0.241141559282107,0.464558980744639,0,0,3.75631528964862,5.34287444203048,LLGL1
Cellular Response To Osmotic Stress (GO:0071470),1/28,0.241141559282107,0.464558980744639,0,0,3.75631528964862,5.34287444203048,YBX3
Fatty Acid Derivative Biosynthetic Process (GO:1901570),1/28,0.241141559282107,0.464558980744639,0,0,3.75631528964862,5.34287444203048,GGT5
Transcription By RNA Polymerase III (GO:0006383),1/28,0.241141559282107,0.464558980744639,0,0,3.75631528964862,5.34287444203048,SNAPC2
Primary Neural Tube Formation (GO:0014020),1/28,0.241141559282107,0.464558980744639,0,0,3.75631528964862,5.34287444203048,FUZ
Protein Depolymerization (GO:0051261),1/28,0.241141559282107,0.464558980744639,0,0,3.75631528964862,5.34287444203048,STMN3
Regulation Of Bone Resorption (GO:0045124),1/28,0.241141559282107,0.464558980744639,0,0,3.75631528964862,5.34287444203048,GPR137
Regulation Of Protein Metabolic Process (GO:0051246),2/96,0.242302600632841,0.465894575734189,0,0,2.16165825839,3.06429739700269,RPL10;ELP5
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),3/174,0.243406669098049,0.467115688673712,0,0,1.78465594036906,2.52175756909531,CXCL8;PRMT1;EIF4A3
JNK Cascade (GO:0007254),1/29,0.248588787227555,0.471608442054562,0,0,3.62197802197802,5.04163115861399,GPS1
RNA Biosynthetic Process (GO:0032774),1/29,0.248588787227555,0.471608442054562,0,0,3.62197802197802,5.04163115861399,TAF13
Establishment Of Mitotic Spindle Orientation (GO:0000132),1/29,0.248588787227555,0.471608442054562,0,0,3.62197802197802,5.04163115861399,ENKD1
Tube Closure (GO:0060606),1/29,0.248588787227555,0.471608442054562,0,0,3.62197802197802,5.04163115861399,FUZ
Vacuolar Acidification (GO:0007035),1/29,0.248588787227555,0.471608442054562,0,0,3.62197802197802,5.04163115861399,CLN6
Protein Insertion Into ER Membrane (GO:0045048),1/29,0.248588787227555,0.471608442054562,0,0,3.62197802197802,5.04163115861399,UBL4A
Phosphatidylinositol Biosynthetic Process (GO:0006661),2/98,0.249555757172085,0.472542840576799,0,0,2.1164089347079,2.93772991534877,PIGQ;TP53INP2
Axon Development (GO:0061564),2/99,0.253185037288984,0.476522329140353,0,0,2.09448400467637,2.87705587577822,MAPK8IP3;LLGL1
Negative Regulation Of Epithelial To Mesenchymal Transition (GO:0010719),1/30,0.255963299287238,0.476522329140353,0,0,3.49690539345712,4.76530713832387,FUZ
Negative Regulation Of Myeloid Leukocyte Differentiation (GO:0002762),1/30,0.255963299287238,0.476522329140353,0,0,3.49690539345712,4.76530713832387,GPR137
Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),1/30,0.255963299287238,0.476522329140353,0,0,3.49690539345712,4.76530713832387,HYAL2
Artery Morphogenesis (GO:0048844),1/30,0.255963299287238,0.476522329140353,0,0,3.49690539345712,4.76530713832387,HES1
Nucleic Acid Metabolic Process (GO:0090304),1/30,0.255963299287238,0.476522329140353,0,0,3.49690539345712,4.76530713832387,RECQL5
Response To Amino Acid (GO:0043200),1/30,0.255963299287238,0.476522329140353,0,0,3.49690539345712,4.76530713832387,SESN2
Maturation Of SSU-rRNA From Tricistronic rRNA Transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462),1/30,0.255963299287238,0.476522329140353,0,0,3.49690539345712,4.76530713832387,TBL3
Regulation Of Arp2/3 Complex-Mediated Actin Nucleation (GO:0034315),1/30,0.255963299287238,0.476522329140353,0,0,3.49690539345712,4.76530713832387,PICK1
ncRNA Processing (GO:0034470),2/100,0.256815610755262,0.477217067746718,0,0,2.07300652219651,2.8180386803121,DDX27;SPPL2B
Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),1/31,0.263265801913915,0.486179002850238,0,0,3.38017094017094,4.51114606508122,GPX1
Regulation Of Protein Localization To Cell Surface (GO:2000008),1/31,0.263265801913915,0.486179002850238,0,0,3.38017094017094,4.51114606508122,TAX1BP3
Central Nervous System Neuron Differentiation (GO:0021953),1/31,0.263265801913915,0.486179002850238,0,0,3.38017094017094,4.51114606508122,NR4A2
Regulation Of Protein Secretion (GO:0050708),2/102,0.264079157170661,0.486179002850238,0,0,2.03134020618557,2.704742450602,PICK1;LLGL1
Protein Catabolic Process (GO:0030163),2/102,0.264079157170661,0.486179002850238,0,0,2.03134020618557,2.704742450602,CLPP;CLN6
Mitochondrial Gene Expression (GO:0140053),2/103,0.267711407516432,0.48807066418141,0,0,2.01112585485353,2.65035359276439,POLRMT;MRPL55
Chromatin Organization (GO:0006325),4/268,0.268775202871708,0.48807066418141,0,0,1.54198232323232,2.02597962044862,TRIM28;RING1;DDX21;CABIN1
NIK/NF-kappaB Signaling (GO:0038061),1/32,0.270496994606564,0.48807066418141,0,0,3.27096774193548,4.27677164950602,MAP3K14
Amide Transport (GO:0042886),1/32,0.270496994606564,0.48807066418141,0,0,3.27096774193548,4.27677164950602,SLC5A6
Neural Tube Closure (GO:0001843),1/32,0.270496994606564,0.48807066418141,0,0,3.27096774193548,4.27677164950602,FUZ
Chromosome Condensation (GO:0030261),1/32,0.270496994606564,0.48807066418141,0,0,3.27096774193548,4.27677164950602,NCAPH2
Glycosphingolipid Metabolic Process (GO:0006687),1/32,0.270496994606564,0.48807066418141,0,0,3.27096774193548,4.27677164950602,CLN6
Protein Transmembrane Import Into Intracellular Organelle (GO:0044743),1/32,0.270496994606564,0.48807066418141,0,0,3.27096774193548,4.27677164950602,DNLZ
Mitochondrial Membrane Organization (GO:0007006),1/32,0.270496994606564,0.48807066418141,0,0,3.27096774193548,4.27677164950602,SLC25A5
Muscle Cell Development (GO:0055001),1/32,0.270496994606564,0.48807066418141,0,0,3.27096774193548,4.27677164950602,HES1
Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134),1/32,0.270496994606564,0.48807066418141,0,0,3.27096774193548,4.27677164950602,PLK3
Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),2/105,0.274975107761453,0.49033145377326,0,0,1.9718746872185,2.54583752545102,PRMT1;MAPK8IP3
Negative Regulation Of MAPK Cascade (GO:0043409),2/105,0.274975107761453,0.49033145377326,0,0,1.9718746872185,2.54583752545102,DUSP2;HYAL2
Cardiac Muscle Contraction (GO:0060048),1/33,0.277657570208954,0.49033145377326,0,0,3.16858974358974,4.06012534021571,GAA
Regulation Of Sprouting Angiogenesis (GO:1903670),1/33,0.277657570208954,0.49033145377326,0,0,3.16858974358974,4.06012534021571,EPN2
Positive Regulation Of DNA Binding (GO:0043388),1/33,0.277657570208954,0.49033145377326,0,0,3.16858974358974,4.06012534021571,HES1
Positive Regulation Of Notch Signaling Pathway (GO:0045747),1/33,0.277657570208954,0.49033145377326,0,0,3.16858974358974,4.06012534021571,EPN2
Positive Regulation Of Chromosome Organization (GO:2001252),1/33,0.277657570208954,0.49033145377326,0,0,3.16858974358974,4.06012534021571,NCAPH2
Signal Transduction By P53 Class Mediator (GO:0072331),1/33,0.277657570208954,0.49033145377326,0,0,3.16858974358974,4.06012534021571,SESN2
Epithelial Tube Morphogenesis (GO:0060562),1/33,0.277657570208954,0.49033145377326,0,0,3.16858974358974,4.06012534021571,HES1
Ubiquitin-Dependent Protein Catabolic Process Via The Multivesicular Body Sorting Pathway (GO:0043162),1/33,0.277657570208954,0.49033145377326,0,0,3.16858974358974,4.06012534021571,RNF126
Protein K63-linked Deubiquitination (GO:0070536),1/33,0.277657570208954,0.49033145377326,0,0,3.16858974358974,4.06012534021571,MPND
Regulation Of Cell Adhesion Mediated By Integrin (GO:0033628),1/33,0.277657570208954,0.49033145377326,0,0,3.16858974358974,4.06012534021571,PLAU
Positive Regulation Of Autophagy (GO:0010508),2/107,0.282235479845609,0.494092721116477,0,0,1.93411880216004,2.44668643707109,PLK3;SESN2
Embryonic Skeletal System Development (GO:0048706),1/34,0.284748214779978,0.494092721116477,0,0,3.07241647241647,3.85941578623469,FUZ
Establishment Of Mitotic Spindle Localization (GO:0040001),1/34,0.284748214779978,0.494092721116477,0,0,3.07241647241647,3.85941578623469,ENKD1
Positive Regulation Of Immunoglobulin Production (GO:0002639),1/34,0.284748214779978,0.494092721116477,0,0,3.07241647241647,3.85941578623469,DNAJB9
Glial Cell Differentiation (GO:0010001),1/34,0.284748214779978,0.494092721116477,0,0,3.07241647241647,3.85941578623469,PICK1
Histone Deubiquitination (GO:0016578),1/34,0.284748214779978,0.494092721116477,0,0,3.07241647241647,3.85941578623469,MPND
Positive Regulation Of Transcription By RNA Polymerase I (GO:0045943),1/34,0.284748214779978,0.494092721116477,0,0,3.07241647241647,3.85941578623469,DDX21
Purine Nucleotide Metabolic Process (GO:0006163),1/34,0.284748214779978,0.494092721116477,0,0,3.07241647241647,3.85941578623469,AMPD2
Negative Regulation Of JNK Cascade (GO:0046329),1/34,0.284748214779978,0.494092721116477,0,0,3.07241647241647,3.85941578623469,PRMT1
Negative Regulation Of Ras Protein Signal Transduction (GO:0046580),1/34,0.284748214779978,0.494092721116477,0,0,3.07241647241647,3.85941578623469,STMN3
Negative Regulation Of Developmental Process (GO:0051093),2/109,0.289489902688074,0.498485848450941,0,0,1.89777435205704,2.35254724517777,NOTCH4;FUZ
Regulation Of Wnt Signaling Pathway (GO:0030111),2/109,0.289489902688074,0.498485848450941,0,0,1.89777435205704,2.35254724517777,TAX1BP3;EMD
Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),6/456,0.290219786762334,0.498485848450941,0,0,1.35817543859649,1.68022159493587,KLF10;TRIM28;RING1;HES1;ZNF653;GZF1
Transcription By RNA Polymerase II (GO:0006366),3/192,0.290983851251601,0.498485848450941,0,0,1.61320832305288,1.99148552153157,SNAPC2;TAF13;DDX21
Neutral Amino Acid Transport (GO:0015804),1/35,0.291769607899645,0.498485848450941,0,0,2.98190045248869,3.67307755042646,SLC7A7
Cellular Response To Amino Acid Stimulus (GO:0071230),1/35,0.291769607899645,0.498485848450941,0,0,2.98190045248869,3.67307755042646,SESN2
Endoderm Formation (GO:0001706),1/35,0.291769607899645,0.498485848450941,0,0,2.98190045248869,3.67307755042646,DUSP2
Protein Methylation (GO:0006479),1/35,0.291769607899645,0.498485848450941,0,0,2.98190045248869,3.67307755042646,PRMT1
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),5/367,0.291784387195681,0.498485848450941,0,0,1.4059471811634,1.73176159108749,PSMB6;UBL4A;KLHDC3;RNF126;UBXN11
Regulation Of JNK Cascade (GO:0046328),2/110,0.293114092237898,0.499900061419429,0,0,1.88010691103475,2.3072547031276,PRMT1;MAPK8IP3
Double-Strand Break Repair Via Homologous Recombination (GO:0000724),2/111,0.296735857860578,0.502580291770833,0,0,1.86276364324222,2.26309558611119,RECQL5;NSMCE1
Mitotic Cell Cycle Phase Transition (GO:0044772),2/111,0.296735857860578,0.502580291770833,0,0,1.86276364324222,2.26309558611119,PLK3;FBXL15
Regulation Of Erythrocyte Differentiation (GO:0045646),1/36,0.298722422418005,0.502580291770833,0,0,2.89655677655678,3.49973717871601,PRMT1
Negative Regulation Of Protein Kinase B Signaling (GO:0051898),1/36,0.298722422418005,0.502580291770833,0,0,2.89655677655678,3.49973717871601,HYAL2
Regulation Of Intracellular Protein Transport (GO:0033157),1/36,0.298722422418005,0.502580291770833,0,0,2.89655677655678,3.49973717871601,PLK3
Regulation Of Receptor Internalization (GO:0002090),1/36,0.298722422418005,0.502580291770833,0,0,2.89655677655678,3.49973717871601,PICK1
Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),1/36,0.298722422418005,0.502580291770833,0,0,2.89655677655678,3.49973717871601,PRMT1
Lytic Vacuole Organization (GO:0080171),1/36,0.298722422418005,0.502580291770833,0,0,2.89655677655678,3.49973717871601,GAA
Positive Regulation Of Protein Metabolic Process (GO:0051247),3/196,0.301667610406283,0.506464052373762,0,0,1.57945179736369,1.89286162073894,PRMT1;EIF4A3;CLN6
Golgi Vesicle Transport (GO:0048193),3/197,0.304342003001661,0.506464052373762,0,0,1.57123016932856,1.86914043745059,VPS51;PICK1;YIF1B
Negative Regulation Of Stress-Activated MAPK Cascade (GO:0032873),1/37,0.305607324775734,0.506464052373762,0,0,2.81595441595442,3.33818513997087,PRMT1
Regulation Of p38MAPK Cascade (GO:1900744),1/37,0.305607324775734,0.506464052373762,0,0,2.81595441595442,3.33818513997087,PRMT1
Ventricular Septum Development (GO:0003281),1/37,0.305607324775734,0.506464052373762,0,0,2.81595441595442,3.33818513997087,HES1
Positive Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046427),1/37,0.305607324775734,0.506464052373762,0,0,2.81595441595442,3.33818513997087,HES1
Positive Regulation Of Receptor Signaling Pathway Via STAT (GO:1904894),1/37,0.305607324775734,0.506464052373762,0,0,2.81595441595442,3.33818513997087,HES1
Melanosome Organization (GO:0032438),1/37,0.305607324775734,0.506464052373762,0,0,2.81595441595442,3.33818513997087,BLOC1S4
Mitochondrion Disassembly (GO:0061726),1/37,0.305607324775734,0.506464052373762,0,0,2.81595441595442,3.33818513997087,MAP1LC3A
Protein Modification By Small Protein Removal (GO:0070646),2/114,0.307583648526255,0.508048613486153,0,0,1.81259204712813,2.13706088863278,GPS1;JOSD1
Negative Regulation Of Canonical Wnt Signaling Pathway (GO:0090090),2/114,0.307583648526255,0.508048613486153,0,0,1.81259204712813,2.13706088863278,FUZ;EMD
Regulation Of Telomere Maintenance (GO:0032204),1/38,0.312424974876054,0.510961042654434,0,0,2.73970893970894,3.18735250123233,NSMCE1
Connective Tissue Development (GO:0061448),1/38,0.312424974876054,0.510961042654434,0,0,2.73970893970894,3.18735250123233,HYAL2
Response To Transforming Growth Factor Beta (GO:0071559),1/38,0.312424974876054,0.510961042654434,0,0,2.73970893970894,3.18735250123233,HYAL2
Positive Regulation Of Production Of Molecular Mediator Of Immune Response (GO:0002702),1/38,0.312424974876054,0.510961042654434,0,0,2.73970893970894,3.18735250123233,DNAJB9
Import Into Cell (GO:0098657),1/38,0.312424974876054,0.510961042654434,0,0,2.73970893970894,3.18735250123233,SLC5A6
mRNA Transcription By RNA Polymerase II (GO:0042789),1/38,0.312424974876054,0.510961042654434,0,0,2.73970893970894,3.18735250123233,TAF13
Cellular Response To Oxidative Stress (GO:0034599),2/117,0.318399207150386,0.51356917974715,0,0,1.76503809950695,2.01999664414246,GPX1;SESN2
Protein Processing (GO:0016485),2/117,0.318399207150386,0.51356917974715,0,0,1.76503809950695,2.01999664414246,F12;RCE1
DNA Repair (GO:0006281),4/291,0.319175729516449,0.51356917974715,0,0,1.41673925667828,1.61793528860267,RECQL5;TRIM28;ZNF668;MPND
Axonal Transport (GO:0098930),1/39,0.319176026368962,0.51356917974715,0,0,2.66747638326586,3.04629143072835,BLOC1S4
Regulation Of Protein Tyrosine Kinase Activity (GO:0061097),1/39,0.319176026368962,0.51356917974715,0,0,2.66747638326586,3.04629143072835,HYAL2
Positive Regulation Of ATP-dependent Activity (GO:0032781),1/39,0.319176026368962,0.51356917974715,0,0,2.66747638326586,3.04629143072835,DNAJB2
Digestive Tract Development (GO:0048565),1/39,0.319176026368962,0.51356917974715,0,0,2.66747638326586,3.04629143072835,CXCL8
Positive Regulation Of Intracellular Transport (GO:0032388),1/39,0.319176026368962,0.51356917974715,0,0,2.66747638326586,3.04629143072835,PLK3
Vesicle Cytoskeletal Trafficking (GO:0099518),1/39,0.319176026368962,0.51356917974715,0,0,2.66747638326586,3.04629143072835,MYO7B
Vitamin Transport (GO:0051180),1/39,0.319176026368962,0.51356917974715,0,0,2.66747638326586,3.04629143072835,SLC5A6
Ribonucleoprotein Complex Biogenesis (GO:0022613),2/118,0.321995957275825,0.517270924914067,0,0,1.74973338073231,1.982826367684,TBL3;SPPL2B
Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001959),1/40,0.325861126476229,0.517635856412,0,0,2.59894806048652,2.91415882710325,SPPL2B
L-alpha-amino Acid Transmembrane Transport (GO:1902475),1/40,0.325861126476229,0.517635856412,0,0,2.59894806048652,2.91415882710325,SLC7A7
Negative Regulation Of Protein Localization (GO:1903828),1/40,0.325861126476229,0.517635856412,0,0,2.59894806048652,2.91415882710325,TAX1BP3
Regulation Of Microtubule Cytoskeleton Organization (GO:0070507),1/40,0.325861126476229,0.517635856412,0,0,2.59894806048652,2.91415882710325,STMN3
Nucleic Acid-Templated Transcription (GO:0097659),1/40,0.325861126476229,0.517635856412,0,0,2.59894806048652,2.91415882710325,NR4A2
Positive Regulation Of Wound Healing (GO:0090303),1/40,0.325861126476229,0.517635856412,0,0,2.59894806048652,2.91415882710325,F12
Negative Regulation Of Cell-Cell Adhesion (GO:0022408),1/40,0.325861126476229,0.517635856412,0,0,2.59894806048652,2.91415882710325,NOTCH4
DNA Duplex Unwinding (GO:0032508),1/41,0.332480916265995,0.525636496191955,0,0,2.53384615384615,2.79020250257046,RECQL5
Regulation Of Release Of Cytochrome C From Mitochondria (GO:0090199),1/41,0.332480916265995,0.525636496191955,0,0,2.53384615384615,2.79020250257046,GPX1
Response To Amino Acid Starvation (GO:1990928),1/41,0.332480916265995,0.525636496191955,0,0,2.53384615384615,2.79020250257046,SESN2
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),9/763,0.333117475973939,0.525808250507201,0,0,1.21597469467652,1.3366724286105,NR4A2;KLF10;PLK3;RPL10;NOTCH4;HES1;SAMD1;GZF1;MXD4
Negative Regulation Of Apoptotic Process (GO:0043066),6/482,0.334803527351265,0.526801694815322,0,0,1.28226448474126,1.40306842307847,NR4A2;PLK3;GPX1;RPL10;HSPA5;MAPK8IP3
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),2/122,0.336333910207422,0.526801694815322,0,0,1.69106529209622,1.84267070268924,PRMT1;EIF4A3
Amino Acid Transmembrane Transport (GO:0003333),1/42,0.339036030498616,0.526801694815322,0,0,2.47191994996873,2.67374947646177,SLC7A7
Regulation Of Osteoclast Differentiation (GO:0045670),1/42,0.339036030498616,0.526801694815322,0,0,2.47191994996873,2.67374947646177,GPR137
Branching Morphogenesis Of An Epithelial Tube (GO:0048754),1/42,0.339036030498616,0.526801694815322,0,0,2.47191994996873,2.67374947646177,NOTCH4
Cellular Response To Amino Acid Starvation (GO:0034198),1/42,0.339036030498616,0.526801694815322,0,0,2.47191994996873,2.67374947646177,SESN2
Embryonic Heart Tube Morphogenesis (GO:0003143),1/42,0.339036030498616,0.526801694815322,0,0,2.47191994996873,2.67374947646177,HES1
Stress-Activated MAPK Cascade (GO:0051403),1/42,0.339036030498616,0.526801694815322,0,0,2.47191994996873,2.67374947646177,GPS1
Substantia Nigra Development (GO:0021762),1/42,0.339036030498616,0.526801694815322,0,0,2.47191994996873,2.67374947646177,HSPA5
Translational Elongation (GO:0006414),1/42,0.339036030498616,0.526801694815322,0,0,2.47191994996873,2.67374947646177,ZNF598
mRNA Splicing, Via Spliceosome (GO:0000398),3/211,0.341836990535423,0.529453829969746,0,0,1.46442805898764,1.5719482582524,TSSC4;EIF4A3;STRAP
Regulation Of DNA Metabolic Process (GO:0051052),2/124,0.343470040310515,0.529453829969746,0,0,1.66317390569545,1.77735975885502,ALYREF;NSMCE1
Regulation Of Chromosome Organization (GO:0033044),1/43,0.345527097871822,0.529453829969746,0,0,2.41294261294261,2.56419600949244,NSMCE1
SCF-dependent Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0031146),1/43,0.345527097871822,0.529453829969746,0,0,2.41294261294261,2.56419600949244,FBXL15
Skeletal System Morphogenesis (GO:0048705),1/43,0.345527097871822,0.529453829969746,0,0,2.41294261294261,2.56419600949244,FUZ
Energy Derivation By Oxidation Of Organic Compounds (GO:0015980),1/43,0.345527097871822,0.529453829969746,0,0,2.41294261294261,2.56419600949244,CYC1
Positive Regulation Of Receptor-Mediated Endocytosis (GO:0048260),1/43,0.345527097871822,0.529453829969746,0,0,2.41294261294261,2.56419600949244,PICK1
Lysosome Organization (GO:0007040),1/43,0.345527097871822,0.529453829969746,0,0,2.41294261294261,2.56419600949244,GAA
mRNA Transcription (GO:0009299),1/43,0.345527097871822,0.529453829969746,0,0,2.41294261294261,2.56419600949244,TAF13
Protein-Containing Complex Organization (GO:0043933),2/126,0.350581792949645,0.53518614044903,0,0,1.63618224143665,1.71498280535279,HES1;LLGL1
Autophagosome Maturation (GO:0097352),1/44,0.351954740957946,0.53518614044903,0,0,2.3567084078712,2.46099909087058,MAP1LC3A
Positive Regulation Of Biosynthetic Process (GO:0009891),1/44,0.351954740957946,0.53518614044903,0,0,2.3567084078712,2.46099909087058,CXCL8
Response To Unfolded Protein (GO:0006986),1/44,0.351954740957946,0.53518614044903,0,0,2.3567084078712,2.46099909087058,DNAJB2
Establishment Of Protein Localization To Mitochondrion (GO:0072655),1/44,0.351954740957946,0.53518614044903,0,0,2.3567084078712,2.46099909087058,DNLZ
Cytosolic Transport (GO:0016482),2/127,0.354127974693805,0.537669912797302,0,0,1.62301030927835,1.68484200439606,RNF126;VPS51
I-kappaB kinase/NF-kappaB Signaling (GO:0007249),1/45,0.358319576299717,0.539918756421359,0,0,2.3030303030303,2.36366913592685,MAP3K14
Organic Hydroxy Compound Transport (GO:0015850),1/45,0.358319576299717,0.539918756421359,0,0,2.3030303030303,2.36366913592685,SLC10A3
Regulation Of Protein Modification Process (GO:0031399),1/45,0.358319576299717,0.539918756421359,0,0,2.3030303030303,2.36366913592685,SESN2
Regulation Of Stem Cell Differentiation (GO:2000736),1/45,0.358319576299717,0.539918756421359,0,0,2.3030303030303,2.36366913592685,HES1
Regulation Of Apoptotic Signaling Pathway (GO:2001233),1/45,0.358319576299717,0.539918756421359,0,0,2.3030303030303,2.36366913592685,NR4A2
Protein Homooligomerization (GO:0051260),2/129,0.361199885591236,0.541380480939429,0,0,1.59728874096923,1.62655709916805,PRMT1;SAMD1
Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042058),1/46,0.364622214517073,0.541380480939429,0,0,2.25173789173789,2.27176370045816,RNF126
Regulation Of Fibroblast Proliferation (GO:0048145),1/46,0.364622214517073,0.541380480939429,0,0,2.25173789173789,2.27176370045816,EMD
Regulation Of mRNA Catabolic Process (GO:0061013),1/46,0.364622214517073,0.541380480939429,0,0,2.25173789173789,2.27176370045816,EIF4A3
Amino Acid Transport (GO:0006865),1/46,0.364622214517073,0.541380480939429,0,0,2.25173789173789,2.27176370045816,SLC7A7
Antiviral Innate Immune Response (GO:0140374),1/46,0.364622214517073,0.541380480939429,0,0,2.25173789173789,2.27176370045816,MARCHF2
Regulation Of Nervous System Development (GO:0051960),1/46,0.364622214517073,0.541380480939429,0,0,2.25173789173789,2.27176370045816,HES1
Response To Hydrogen Peroxide (GO:0042542),1/46,0.364622214517073,0.541380480939429,0,0,2.25173789173789,2.27176370045816,GPX1
Vacuolar Transport (GO:0007034),1/46,0.364622214517073,0.541380480939429,0,0,2.25173789173789,2.27176370045816,VPS51
Golgi Organization (GO:0007030),2/130,0.364725203524455,0.541380480939429,0,0,1.5847293814433,1.59837560659056,PLK3;VPS51
Positive Regulation Of Cell Motility (GO:2000147),3/221,0.368551731604472,0.546246316485199,0,0,1.39653943052717,1.39398961896563,HSPA5;PLAU;ELP5
Golgi To Plasma Membrane Transport (GO:0006893),1/47,0.370863260373481,0.546419833331341,0,0,2.20267558528428,2.18488205193548,LLGL1
Regulation Of Signal Transduction By P53 Class Mediator (GO:1901796),1/47,0.370863260373481,0.546419833331341,0,0,2.20267558528428,2.18488205193548,PLK3
Regulation Of Wound Healing (GO:0061041),1/47,0.370863260373481,0.546419833331341,0,0,2.20267558528428,2.18488205193548,PLAU
Secondary Alcohol Metabolic Process (GO:1902652),1/47,0.370863260373481,0.546419833331341,0,0,2.20267558528428,2.18488205193548,CLN6
Cellular Response To Mechanical Stimulus (GO:0071260),1/48,0.377043312650082,0.551446607047696,0,0,2.1557010365521,2.10266046625212,MAP3K14
Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010803),1/48,0.377043312650082,0.551446607047696,0,0,2.1557010365521,2.10266046625212,SPPL2B
Retrograde Vesicle-Mediated Transport, Golgi To Endoplasmic Reticulum (GO:0006890),1/48,0.377043312650082,0.551446607047696,0,0,2.1557010365521,2.10266046625212,PICK1
Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),1/48,0.377043312650082,0.551446607047696,0,0,2.1557010365521,2.10266046625212,DCXR
Regulation Of DNA Binding (GO:0051101),1/48,0.377043312650082,0.551446607047696,0,0,2.1557010365521,2.10266046625212,HES1
Neurogenesis (GO:0022008),1/49,0.383162964498665,0.556312409097188,0,0,2.11068376068376,2.02476813658279,BTBD6
Autophagy Of Mitochondrion (GO:0000422),1/49,0.383162964498665,0.556312409097188,0,0,2.11068376068376,2.02476813658279,MAP1LC3A
Erythrocyte Differentiation (GO:0030218),1/49,0.383162964498665,0.556312409097188,0,0,2.11068376068376,2.02476813658279,SLC25A5
Fatty Acid Beta-Oxidation (GO:0006635),1/49,0.383162964498665,0.556312409097188,0,0,2.11068376068376,2.02476813658279,ECI1
Negative Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043154),1/49,0.383162964498665,0.556312409097188,0,0,2.11068376068376,2.02476813658279,GPX1
Chromatin Remodeling (GO:0006338),3/228,0.387145788721487,0.561276863997963,0,0,1.3526079447323,1.28356264093006,GPX1;RING1;DDX21
Blood Circulation (GO:0008015),1/50,0.389222803095677,0.561834654903325,0,0,2.06750392464678,1.95090361026202,GPX1
Ribosome Assembly (GO:0042255),1/50,0.389222803095677,0.561834654903325,0,0,2.06750392464678,1.95090361026202,RPL10
tRNA Processing (GO:0008033),1/50,0.389222803095677,0.561834654903325,0,0,2.06750392464678,1.95090361026202,ELP5
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),3/231,0.395077091804599,0.566392110182977,0,0,1.3346059449141,1.23941432708167,DUSP2;HYAL2;DDIT4
Regulation Of Smoothened Signaling Pathway (GO:0008589),1/51,0.395223410218041,0.566392110182977,0,0,2.02605128205128,1.88079166834016,FUZ
Regulation Of Stress-Activated MAPK Cascade (GO:0032872),1/51,0.395223410218041,0.566392110182977,0,0,2.02605128205128,1.88079166834016,MAPK8IP3
Receptor Internalization (GO:0031623),1/51,0.395223410218041,0.566392110182977,0,0,2.02605128205128,1.88079166834016,CXCL8
Negative Regulation Of MAP Kinase Activity (GO:0043407),1/51,0.395223410218041,0.566392110182977,0,0,2.02605128205128,1.88079166834016,HYAL2
Rho Protein Signal Transduction (GO:0007266),1/52,0.401165361796443,0.566752766452848,0,0,1.98622423328306,1.81418059490481,TAX1BP3
Regulation Of Peptide Hormone Secretion (GO:0090276),1/52,0.401165361796443,0.566752766452848,0,0,1.98622423328306,1.81418059490481,PICK1
Regulation Of Protein Localization To Nucleus (GO:1900180),1/52,0.401165361796443,0.566752766452848,0,0,1.98622423328306,1.81418059490481,SESN2
Cardiac Muscle Tissue Development (GO:0048738),1/52,0.401165361796443,0.566752766452848,0,0,1.98622423328306,1.81418059490481,PRMT1
Cartilage Development (GO:0051216),1/52,0.401165361796443,0.566752766452848,0,0,1.98622423328306,1.81418059490481,HYAL2
Regulation Of Proteolysis (GO:0030162),1/52,0.401165361796443,0.566752766452848,0,0,1.98622423328306,1.81418059490481,CLN6
Cell Cycle G1/S Phase Transition (GO:0044843),1/52,0.401165361796443,0.566752766452848,0,0,1.98622423328306,1.81418059490481,PLK3
Fatty Acid Oxidation (GO:0019395),1/52,0.401165361796443,0.566752766452848,0,0,1.98622423328306,1.81418059490481,ECI1
Positive Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060261),1/52,0.401165361796443,0.566752766452848,0,0,1.98622423328306,1.81418059490481,TAF13
Regulation Of Cell Development (GO:0060284),1/52,0.401165361796443,0.566752766452848,0,0,1.98622423328306,1.81418059490481,HES1
Blood Vessel Morphogenesis (GO:0048514),1/53,0.407049228299801,0.571015537164228,0,0,1.94792899408284,1.75083977234715,HES1
Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),1/53,0.407049228299801,0.571015537164228,0,0,1.94792899408284,1.75083977234715,GPX1
mRNA Stabilization (GO:0048255),1/53,0.407049228299801,0.571015537164228,0,0,1.94792899408284,1.75083977234715,YBX3
Mitochondrial Transport (GO:0006839),1/53,0.407049228299801,0.571015537164228,0,0,1.94792899408284,1.75083977234715,SLC25A5
Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),1/53,0.407049228299801,0.571015537164228,0,0,1.94792899408284,1.75083977234715,GPX1
Nucleosome Assembly (GO:0006334),1/54,0.412875574665973,0.575624805933265,0,0,1.91107885824867,1.69055756422917,CABIN1
Organelle Disassembly (GO:1903008),1/54,0.412875574665973,0.575624805933265,0,0,1.91107885824867,1.69055756422917,PLK3
Ribosomal Large Subunit Biogenesis (GO:0042273),1/54,0.412875574665973,0.575624805933265,0,0,1.91107885824867,1.69055756422917,RPL10
Monoatomic Anion Transmembrane Transport (GO:0098656),1/54,0.412875574665973,0.575624805933265,0,0,1.91107885824867,1.69055756422917,SLC5A6
Regulation Of Cell Adhesion (GO:0030155),2/144,0.41322463478141,0.575624805933265,0,0,1.42747204878757,1.26154829924271,CXCL8;PLAU
Ceramide Metabolic Process (GO:0006672),1/55,0.418644960323953,0.580738691480024,0,0,1.87559354226021,1.63313944439141,CLN6
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),1/55,0.418644960323953,0.580738691480024,0,0,1.87559354226021,1.63313944439141,HES1
Purine Ribonucleotide Biosynthetic Process (GO:0009152),1/55,0.418644960323953,0.580738691480024,0,0,1.87559354226021,1.63313944439141,AMPD2
Regulation Of Cell Migration (GO:0030334),5/434,0.421257565822197,0.58355011899709,0,0,1.18228194144425,1.02209555084843,HSPA5;PLAU;OSGIN1;FUZ;ELP5
RNA Polymerase II Preinitiation Complex Assembly (GO:0051123),1/56,0.424357939288644,0.584592679849916,0,0,1.8413986013986,1.57840633987099,TAF13
Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000377),1/56,0.424357939288644,0.584592679849916,0,0,1.8413986013986,1.57840633987099,DCXR
Positive Regulation Of DNA-templated Transcription Initiation (GO:2000144),1/56,0.424357939288644,0.584592679849916,0,0,1.8413986013986,1.57840633987099,TAF13
post-Golgi Vesicle-Mediated Transport (GO:0006892),1/56,0.424357939288644,0.584592679849916,0,0,1.8413986013986,1.57840633987099,LLGL1
Defense Response To Symbiont (GO:0140546),2/148,0.426751152505669,0.587077552342053,0,0,1.38808077955091,1.18202604088232,DDIT4;MAP3K14
Regulation Of Transcription Initiation By RNA Polymerase II (GO:0060260),1/57,0.4300150603371,0.587510288197191,0,0,1.80842490842491,1.52619315984899,TAF13
Chemokine-Mediated Signaling Pathway (GO:0070098),1/57,0.4300150603371,0.587510288197191,0,0,1.80842490842491,1.52619315984899,CXCL8
Signal Transduction In Response To DNA Damage (GO:0042770),1/57,0.4300150603371,0.587510288197191,0,0,1.80842490842491,1.52619315984899,SESN2
Striated Muscle Contraction (GO:0006941),1/57,0.4300150603371,0.587510288197191,0,0,1.80842490842491,1.52619315984899,GAA
Myeloid Cell Differentiation (GO:0030099),1/57,0.4300150603371,0.587510288197191,0,0,1.80842490842491,1.52619315984899,SLC25A5
Renal System Development (GO:0072001),1/58,0.43561686677755,0.592182265580332,0,0,1.7766081871345,1.4763474888997,HYAL2
Muscle Organ Development (GO:0007517),1/58,0.43561686677755,0.592182265580332,0,0,1.7766081871345,1.4763474888997,EMD
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),10/938,0.438608707183582,0.592182265580332,0,0,1.09357619577308,0.901268187294704,NR4A2;KLF10;TAF13;HYAL2;NOTCH4;MEPCE;PTOV1;DDX21;HES1;SSBP3
Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),1/59,0.441163896647195,0.592182265580332,0,0,1.74588859416446,1.42872842047303,HSPA5
Anterior/Posterior Pattern Specification (GO:0009952),1/59,0.441163896647195,0.592182265580332,0,0,1.74588859416446,1.42872842047303,HES1
Cellular Response To Chemokine (GO:1990869),1/59,0.441163896647195,0.592182265580332,0,0,1.74588859416446,1.42872842047303,CXCL8
Chordate Embryonic Development (GO:0043009),1/59,0.441163896647195,0.592182265580332,0,0,1.74588859416446,1.42872842047303,FUZ
Transcription Preinitiation Complex Assembly (GO:0070897),1/59,0.441163896647195,0.592182265580332,0,0,1.74588859416446,1.42872842047303,TAF13
Heart Morphogenesis (GO:0003007),1/59,0.441163896647195,0.592182265580332,0,0,1.74588859416446,1.42872842047303,HES1
Positive Regulation Of Proteolysis (GO:0045862),1/59,0.441163896647195,0.592182265580332,0,0,1.74588859416446,1.42872842047303,CLN6
Microtubule Cytoskeleton Organization Involved In Mitosis (GO:1902850),1/59,0.441163896647195,0.592182265580332,0,0,1.74588859416446,1.42872842047303,PLK3
Protein Targeting To Mitochondrion (GO:0006626),1/59,0.441163896647195,0.592182265580332,0,0,1.74588859416446,1.42872842047303,DNLZ
protein-DNA Complex Assembly (GO:0065004),1/59,0.441163896647195,0.592182265580332,0,0,1.74588859416446,1.42872842047303,CABIN1
Sterol Metabolic Process (GO:0016125),1/60,0.446656683012462,0.597943624032813,0,0,1.71621034332899,1.38320551470295,CLN6
protein-DNA Complex Organization (GO:0071824),1/60,0.446656683012462,0.597943624032813,0,0,1.71621034332899,1.38320551470295,TRIM28
Positive Regulation Of Response To External Stimulus (GO:0032103),2/155,0.450024610994999,0.601643641008079,0,0,1.32410214945085,1.05723334229213,PLAU;HYAL2
Negative Regulation Of Intrinsic Apoptotic Signaling Pathway (GO:2001243),1/61,0.452095753492131,0.602794337989509,0,0,1.68752136752137,1.33965786875822,YBX3
Positive Regulation Of Interleukin-8 Production (GO:0032757),1/61,0.452095753492131,0.602794337989509,0,0,1.68752136752137,1.33965786875822,HYAL2
RNA Methylation (GO:0001510),1/62,0.457481630793682,0.607535605694009,0,0,1.65977301387137,1.29797327956751,MEPCE
Fat Cell Differentiation (GO:0045444),1/62,0.457481630793682,0.607535605694009,0,0,1.65977301387137,1.29797327956751,NR4A2
Protein-Containing Complex Disassembly (GO:0032984),1/62,0.457481630793682,0.607535605694009,0,0,1.65977301387137,1.29797327956751,MAP1LC3A
G1/S Transition Of Mitotic Cell Cycle (GO:0000082),1/63,0.462814832444138,0.612169419806588,0,0,1.63291976840364,1.25804749476651,PLK3
Inorganic Anion Transmembrane Transport (GO:0098661),1/63,0.462814832444138,0.612169419806588,0,0,1.63291976840364,1.25804749476651,SLC5A6
Regulation Of Cellular Catabolic Process (GO:0031329),1/63,0.462814832444138,0.612169419806588,0,0,1.63291976840364,1.25804749476651,GPR137
Regulation Of Secretion By Cell (GO:1903530),1/64,0.468095870992872,0.616697734800132,0,0,1.60691900691901,1.21978353705035,LLGL1
Response To Metal Ion (GO:0010038),1/64,0.468095870992872,0.616697734800132,0,0,1.60691900691901,1.21978353705035,IMPA2
Endocytic Recycling (GO:0032456),1/64,0.468095870992872,0.616697734800132,0,0,1.60691900691901,1.21978353705035,VPS51
Cellular Component Assembly (GO:0022607),3/260,0.470021958559338,0.618417266479658,0,0,1.18225439003246,0.892573530800715,MYO7B;HES1;LLGL1
Antimicrobial Humoral Immune Response Mediated By Antimicrobial Peptide (GO:0061844),1/65,0.473325254114177,0.619490082914218,0,0,1.58173076923077,1.18309109560228,CXCL8
Canonical Wnt Signaling Pathway (GO:0060070),1/65,0.473325254114177,0.619490082914218,0,0,1.58173076923077,1.18309109560228,NR4A2
Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),1/65,0.473325254114177,0.619490082914218,0,0,1.58173076923077,1.18309109560228,HES1
Regulation Of Cell-Matrix Adhesion (GO:0001952),1/65,0.473325254114177,0.619490082914218,0,0,1.58173076923077,1.18309109560228,PLAU
Negative Regulation Of Cell Migration (GO:0030336),2/163,0.475960682890329,0.622121837478698,0,0,1.25779599154767,0.933812934171466,HYAL2;FUZ
Regulation Of Neurogenesis (GO:0050767),1/67,0.483631059879667,0.628846652271734,0,0,1.53364413364413,1.11408961065832,HES1
Regulation Of Viral Genome Replication (GO:0045069),1/67,0.483631059879667,0.628846652271734,0,0,1.53364413364413,1.11408961065832,CXCL8
Cholesterol Metabolic Process (GO:0008203),1/67,0.483631059879667,0.628846652271734,0,0,1.53364413364413,1.11408961065832,CLN6
tRNA Modification (GO:0006400),1/67,0.483631059879667,0.628846652271734,0,0,1.53364413364413,1.11408961065832,ELP5
Positive Regulation Of Signal Transduction (GO:0009967),3/266,0.485030870058799,0.629844519659145,0,0,1.15492819007467,0.835639907686251,NECAB2;VWF;EPN2
Membrane Organization (GO:0061024),2/167,0.488649717454446,0.63214758370591,0,0,1.22705404561075,0.878704900066367,PICK1;EMD
Neuropeptide Signaling Pathway (GO:0007218),1/68,0.488708473346939,0.63214758370591,0,0,1.51067738231917,1.08162859421179,KISS1R
Cell-Cell Junction Organization (GO:0045216),1/68,0.488708473346939,0.63214758370591,0,0,1.51067738231917,1.08162859421179,PARD6A
DNA-templated DNA Replication (GO:0006261),1/69,0.49373621312304,0.636004998214704,0,0,1.48838612368024,1.05043429057459,RECQL5
Response To Molecule Of Bacterial Origin (GO:0002237),1/69,0.49373621312304,0.636004998214704,0,0,1.48838612368024,1.05043429057459,CXCL8
Establishment Of Protein Localization To Membrane (GO:0090150),1/69,0.49373621312304,0.636004998214704,0,0,1.48838612368024,1.05043429057459,YIF1B
Brain Development (GO:0007420),2/169,0.494922292767831,0.636004998214704,0,0,1.2122353231681,0.852631185421857,VPS51;DDIT4
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),1/70,0.498714762656309,0.636004998214704,0,0,1.46674098848012,1.02044245530858,GPX1
Neutrophil Chemotaxis (GO:0030593),1/70,0.498714762656309,0.636004998214704,0,0,1.46674098848012,1.02044245530858,CXCL8
Sensory Organ Development (GO:0007423),1/70,0.498714762656309,0.636004998214704,0,0,1.46674098848012,1.02044245530858,MYO7B
Sulfur Compound Biosynthetic Process (GO:0044272),1/70,0.498714762656309,0.636004998214704,0,0,1.46674098848012,1.02044245530858,GGT5
Positive Regulation Of Protein Transport (GO:0051222),1/70,0.498714762656309,0.636004998214704,0,0,1.46674098848012,1.02044245530858,PLK3
Protein K48-linked Ubiquitination (GO:0070936),1/70,0.498714762656309,0.636004998214704,0,0,1.46674098848012,1.02044245530858,RNF126
Regulation Of G Protein-Coupled Receptor Signaling Pathway (GO:0008277),1/70,0.498714762656309,0.636004998214704,0,0,1.46674098848012,1.02044245530858,CXCL8
Positive Regulation Of Cell Migration (GO:0030335),3/272,0.499835840608877,0.636619561696216,0,0,1.1288210027544,0.782809769406006,HSPA5;PLAU;ELP5
Regulation Of Hydrolase Activity (GO:0051336),1/71,0.50364460085298,0.638148355478086,0,0,1.44571428571429,0.991592899555622,STMN3
Negative Regulation Of Protein Binding (GO:0032091),1/71,0.50364460085298,0.638148355478086,0,0,1.44571428571429,0.991592899555622,DNAJB2
Kidney Development (GO:0001822),1/71,0.50364460085298,0.638148355478086,0,0,1.44571428571429,0.991592899555622,HYAL2
Negative Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090288),1/71,0.50364460085298,0.638148355478086,0,0,1.44571428571429,0.991592899555622,EPN2
Generation Of Neurons (GO:0048699),2/172,0.504239714619733,0.638148355478086,0,0,1.19066100667071,0.815249758269751,NR4A2;DDIT4
Regulation Of Cellular Localization (GO:0060341),1/72,0.50852620181802,0.641129236722466,0,0,1.42527988443481,0.96382918408708,PARD6A
Cellular Response To Hypoxia (GO:0071456),1/72,0.50852620181802,0.641129236722466,0,0,1.42527988443481,0.96382918408708,PLK3
Second-Messenger-Mediated Signaling (GO:0019932),1/72,0.50852620181802,0.641129236722466,0,0,1.42527988443481,0.96382918408708,CXCL8
DNA Replication (GO:0006260),1/73,0.513360035182658,0.643260607148927,0,0,1.40541310541311,0.93709833863521,RECQL5
Cellular Response To Decreased Oxygen Levels (GO:0036294),1/73,0.513360035182658,0.643260607148927,0,0,1.40541310541311,0.93709833863521,PICK1
Granulocyte Chemotaxis (GO:0071621),1/73,0.513360035182658,0.643260607148927,0,0,1.40541310541311,0.93709833863521,CXCL8
Protein Tetramerization (GO:0051262),1/73,0.513360035182658,0.643260607148927,0,0,1.40541310541311,0.93709833863521,FKRP
Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),2/175,0.513445966549595,0.643260607148927,0,0,1.16983493236398,0.779824226900233,DDX21;MAP3K14
Negative Regulation Of Programmed Cell Death (GO:0043069),4/381,0.515078563514365,0.644495288015461,0,0,1.07355216622458,0.712232982581532,PLK3;RPL10;HSPA5;MAPK8IP3
Import Into Nucleus (GO:0051170),1/74,0.518146565958624,0.647520677157829,0,0,1.38609062170706,0.911350606909595,NXT1
Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),1/75,0.522886254743835,0.650993387156075,0,0,1.36729036729037,0.886539212524585,FUZ
Nucleosome Organization (GO:0034728),1/75,0.522886254743835,0.650993387156075,0,0,1.36729036729037,0.886539212524585,CABIN1
Regulation Of BMP Signaling Pathway (GO:0030510),1/75,0.522886254743835,0.650993387156075,0,0,1.36729036729037,0.886539212524585,FBXL15
Wnt Signaling Pathway (GO:0016055),1/76,0.527579557565498,0.654382614365175,0,0,1.34899145299145,0.862620145678394,NR4A2
Positive Regulation Of Interleukin-6 Production (GO:0032755),1/76,0.527579557565498,0.654382614365175,0,0,1.34899145299145,0.862620145678394,HYAL2
Transcription Initiation At RNA Polymerase II Promoter (GO:0006367),1/76,0.527579557565498,0.654382614365175,0,0,1.34899145299145,0.862620145678394,TAF13
Endosomal Transport (GO:0016197),2/180,0.528538817917983,0.654441998008203,0,0,1.13668481408549,0.724794599017421,RNF126;VPS51
Regulation Of Immune Response (GO:0050776),1/77,0.532226926091008,0.654441998008203,0,0,1.33117408906883,0.839551966704111,SPPL2B
Negative Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0030512),1/77,0.532226926091008,0.654441998008203,0,0,1.33117408906883,0.839551966704111,STRAP
Neutrophil Migration (GO:1990266),1/77,0.532226926091008,0.654441998008203,0,0,1.33117408906883,0.839551966704111,CXCL8
Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),1/77,0.532226926091008,0.654441998008203,0,0,1.33117408906883,0.839551966704111,LLGL1
Positive Regulation Of JNK Cascade (GO:0046330),1/77,0.532226926091008,0.654441998008203,0,0,1.33117408906883,0.839551966704111,MAPK8IP3
Positive Regulation Of Response To Stimulus (GO:0048584),1/77,0.532226926091008,0.654441998008203,0,0,1.33117408906883,0.839551966704111,TRIM28
Organonitrogen Compound Catabolic Process (GO:1901565),1/78,0.536828807604826,0.657607171424543,0,0,1.31381951381951,0.817295626414262,CLN6
Proteolysis Involved In Protein Catabolic Process (GO:0051603),1/78,0.536828807604826,0.657607171424543,0,0,1.31381951381951,0.817295626414262,CLPP
Regulation Of TOR Signaling (GO:0032006),1/78,0.536828807604826,0.657607171424543,0,0,1.31381951381951,0.817295626414262,DDIT4
Macromolecule Biosynthetic Process (GO:0009059),2/183,0.537442005561825,0.657607171424543,0,0,1.11767386227715,0.694002173021327,RPL10;MRPL55
DNA Metabolic Process (GO:0006259),3/288,0.538230377465014,0.657763749638226,0,0,1.06457594764112,0.659471371426436,RECQL5;TRIM28;ZNF668
Regulation Of Neuron Differentiation (GO:0045664),1/79,0.541385645050414,0.658388403504532,0,0,1.29690992767916,0.795814300912557,HES1
Cellular Response To UV (GO:0034644),1/79,0.541385645050414,0.658388403504532,0,0,1.29690992767916,0.795814300912557,HYAL2
Positive Regulation Of Protein Localization To Membrane (GO:1905477),1/79,0.541385645050414,0.658388403504532,0,0,1.29690992767916,0.795814300912557,NECAB2
Protein Import Into Nucleus (GO:0006606),1/79,0.541385645050414,0.658388403504532,0,0,1.29690992767916,0.795814300912557,NXT1
Regulation Of Cytokinesis (GO:0032465),1/80,0.545897877133559,0.661452902220225,0,0,1.28042843232717,0.775073239548783,PLK3
Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),1/80,0.545897877133559,0.661452902220225,0,0,1.28042843232717,0.775073239548783,HYAL2
Regulation Of Organelle Assembly (GO:1902115),1/80,0.545897877133559,0.661452902220225,0,0,1.28042843232717,0.775073239548783,FUZ
Regulation Of Interleukin-8 Production (GO:0032677),1/81,0.550365938261611,0.665248148675442,0,0,1.26435897435897,0.755039625338365,HYAL2
Macromolecule Modification (GO:0043412),1/81,0.550365938261611,0.665248148675442,0,0,1.26435897435897,0.755039625338365,UBL4A
Regulation Of Phosphorylation (GO:0042325),1/82,0.554790258507626,0.669783148452843,0,0,1.24868629313074,0.735682446273206,SESN2
Epigenetic Regulation Of Gene Expression (GO:0040029),1/83,0.559171264091926,0.671814932491627,0,0,1.23339587242026,0.716972375467317,GPX1
Vascular Transport (GO:0010232),1/83,0.559171264091926,0.671814932491627,0,0,1.23339587242026,0.716972375467317,SLC5A6
Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),1/83,0.559171264091926,0.671814932491627,0,0,1.23339587242026,0.716972375467317,DNAJB2
Regulation Of Cell Division (GO:0051302),1/83,0.559171264091926,0.671814932491627,0,0,1.23339587242026,0.716972375467317,PLK3
Modification-Dependent Protein Catabolic Process (GO:0019941),2/192,0.563454481822817,0.674056965850504,0,0,1.06424308193163,0.610522973353686,UBL4A;RNF126
Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),1/84,0.56350937676364,0.674056965850504,0,0,1.21847389558233,0.69888166291098,GPX1
Purine Ribonucleotide Metabolic Process (GO:0009150),1/84,0.56350937676364,0.674056965850504,0,0,1.21847389558233,0.69888166291098,AMPD2
Regulation Of Signal Transduction (GO:0009966),2/193,0.56627963244129,0.674056965850504,0,0,1.05861715334377,0.602000929247557,FUZ;LLGL1
Nuclear-Transcribed mRNA Catabolic Process (GO:0000956),1/85,0.567805014406197,0.674056965850504,0,0,1.2039072039072,0.68138403277293,EIF4A3
Calcium-Mediated Signaling (GO:0019722),1/85,0.567805014406197,0.674056965850504,0,0,1.2039072039072,0.68138403277293,CXCL8
Establishment Of Protein Localization To Organelle (GO:0072594),1/85,0.567805014406197,0.674056965850504,0,0,1.2039072039072,0.68138403277293,NXT1
Transport Across Blood-Brain Barrier (GO:0150104),1/85,0.567805014406197,0.674056965850504,0,0,1.2039072039072,0.68138403277293,SLC5A6
Macromolecule Catabolic Process (GO:0009057),1/85,0.567805014406197,0.674056965850504,0,0,1.2039072039072,0.68138403277293,CLN6
Mitotic Spindle Organization (GO:0007052),1/85,0.567805014406197,0.674056965850504,0,0,1.2039072039072,0.68138403277293,PLK3
Negative Regulation Of Angiogenesis (GO:0016525),1/86,0.572058590819693,0.677491505893477,0,0,1.18968325791855,0.664454590157742,EPN2
Negative Regulation Of Binding (GO:0051100),1/86,0.572058590819693,0.677491505893477,0,0,1.18968325791855,0.664454590157742,DNAJB2
Regulation Of Insulin Secretion (GO:0050796),1/87,0.576270515660583,0.681669161042684,0,0,1.1757901013715,0.64806973442646,PICK1
Negative Regulation Of Protein Kinase Activity (GO:0006469),1/88,0.580441194821381,0.68578817324092,0,0,1.16221632773357,0.632207077977145,HYAL2
Cellular Response To Cytokine Stimulus (GO:0071345),3/308,0.583787298775084,0.686595219302403,0,0,0.993748407372802,0.53485385363501,CXCL8;HYAL2;YBX3
Cellular Response To Peptide Hormone Stimulus (GO:0071375),1/89,0.584571030088793,0.686595219302403,0,0,1.14895104895105,0.616845372353231,NR4A2
Positive Regulation Of DNA Repair (GO:0045739),1/89,0.584571030088793,0.686595219302403,0,0,1.14895104895105,0.616845372353231,TRIM28
Sensory Perception Of Mechanical Stimulus (GO:0050954),1/89,0.584571030088793,0.686595219302403,0,0,1.14895104895105,0.616845372353231,MYO7B
Sodium Ion Transport (GO:0006814),1/89,0.584571030088793,0.686595219302403,0,0,1.14895104895105,0.616845372353231,SLC5A6
Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),1/90,0.588660419508591,0.690583955041881,0,0,1.13598386632094,0.601964438253214,DNAJB2
Regulation Of Epithelial Cell Proliferation (GO:0050678),1/91,0.592709757017092,0.693700256156314,0,0,1.12330484330484,0.587545101914478,GPX1
Positive Regulation Of Binding (GO:0051099),1/91,0.592709757017092,0.693700256156314,0,0,1.12330484330484,0.587545101914478,HES1
Sensory Perception Of Sound (GO:0007605),1/92,0.596719432987661,0.696755633359567,0,0,1.11090448013525,0.573569134225868,MYO7B
Positive Regulation Of Protein Catabolic Process (GO:0045732),1/92,0.596719432987661,0.696755633359567,0,0,1.11090448013525,0.573569134225868,PLK3
Protein O-linked Glycosylation (GO:0006493),1/93,0.600689833899216,0.699525577290875,0,0,1.09877369007804,0.560019195704991,FKRP
Negative Regulation Of Amide Metabolic Process (GO:0034249),1/93,0.600689833899216,0.699525577290875,0,0,1.09877369007804,0.560019195704991,EIF4A3
Supramolecular Fiber Organization (GO:0097435),3/316,0.601198688916656,0.699525577290875,0,0,0.967951795262295,0.492522720215654,PLK3;MYO7B;STMN3
Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),2/207,0.604451015260852,0.701051056099193,0,0,0.985617299471964,0.496193895947068,FUZ;EMD
Negative Regulation Of Cell Differentiation (GO:0045596),2/207,0.604451015260852,0.701051056099193,0,0,0.985617299471964,0.496193895947068,NOTCH4;HES1
Muscle Contraction (GO:0006936),1/94,0.604621342559445,0.701051056099193,0,0,1.08690377722636,0.546878784231492,EMD
Protein Stabilization (GO:0050821),2/208,0.607078666937801,0.703081804965174,0,0,0.980782704433991,0.489505604170936,DNLZ;MAPK8IP3
Positive Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090100),1/95,0.608514337922192,0.703925993693964,0,0,1.07528641571195,0.534132187060636,FBXL15
Regulation Of Macroautophagy (GO:0016241),1/96,0.612369195433249,0.705925600291107,0,0,1.06391363022942,0.521764435132821,SESN2
Cellular Response To Transforming Growth Factor Beta Stimulus (GO:0071560),1/96,0.612369195433249,0.705925600291107,0,0,1.06391363022942,0.521764435132821,HYAL2
Positive Regulation Of Supramolecular Fiber Organization (GO:1902905),1/96,0.612369195433249,0.705925600291107,0,0,1.06391363022942,0.521764435132821,GPX1
Organelle Assembly (GO:0070925),3/322,0.613941942925693,0.706920433704035,0,0,0.949453440966752,0.463195523752785,MAP1LC3A;TP53INP2;FUZ
Nervous System Development (GO:0007399),4/433,0.616183428880994,0.708126279865006,0,0,0.940899378399378,0.455593439021515,STMN3;FUZ;HES1;BTBD6
Protein Ubiquitination (GO:0016567),4/434,0.617996691466908,0.708126279865006,0,0,0.938662790697674,0.451752283013499,RNF126;MARCHF2;FBXL15;ZNF598
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),1/98,0.619965979962134,0.708126279865006,0,0,1.04187153053132,0.498109061708531,EIF4A3
MAPK Cascade (GO:0000165),1/98,0.619965979962134,0.708126279865006,0,0,1.04187153053132,0.498109061708531,RCE1
RNA Splicing (GO:0008380),1/98,0.619965979962134,0.708126279865006,0,0,1.04187153053132,0.498109061708531,PRMT1
Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),1/98,0.619965979962134,0.708126279865006,0,0,1.04187153053132,0.498109061708531,G0S2
Mitochondrial Translation (GO:0032543),1/98,0.619965979962134,0.708126279865006,0,0,1.04187153053132,0.498109061708531,MRPL55
mRNA Processing (GO:0006397),2/214,0.622567865680669,0.710283613078976,0,0,0.952732931336316,0.451502647003971,ALYREF;EIF4A3
Antimicrobial Humoral Response (GO:0019730),1/100,0.627414626895937,0.713361836059764,0,0,1.02072002072002,0.475806259368427,CXCL8
Regulation Of Organelle Organization (GO:0033043),1/100,0.627414626895937,0.713361836059764,0,0,1.02072002072002,0.475806259368427,STMN3
Response To UV (GO:0009411),1/100,0.627414626895937,0.713361836059764,0,0,1.02072002072002,0.475806259368427,GPX1
Hemopoiesis (GO:0030097),1/101,0.631084299086132,0.716716034081855,0,0,1.01046153846154,0.4651314411012,NOTCH4
Activation Of GTPase Activity (GO:0090630),1/102,0.634718010348867,0.72002179761671,0,0,1.0004061944656,0.454759102540728,TAX1BP3
Positive Regulation Of Inflammatory Response (GO:0050729),1/104,0.641878949062623,0.725665645024259,0,0,0.980881254667662,0.434879144158098,HYAL2
Positive Regulation Of Vasculature Development (GO:1904018),1/104,0.641878949062623,0.725665645024259,0,0,0.980881254667662,0.434879144158098,CXCL8
Macroautophagy (GO:0016236),1/104,0.641878949062623,0.725665645024259,0,0,0.980881254667662,0.434879144158098,MAP1LC3A
Cellular Response To Organonitrogen Compound (GO:0071417),1/105,0.64540686754301,0.728001404386,0,0,0.971400394477318,0.425351324739948,SESN2
Lysosomal Transport (GO:0007041),1/105,0.64540686754301,0.728001404386,0,0,0.971400394477318,0.425351324739948,VPS51
Protein Polyubiquitination (GO:0000209),2/226,0.652130361965724,0.73418064210355,0,0,0.901141384388807,0.385247669986229,RNF126;ZNF598
Negative Regulation Of Translation (GO:0017148),1/107,0.652359305483576,0.73418064210355,0,0,0.952975326560232,0.407072737333803,EIF4A3
Positive Regulation Of DNA Metabolic Process (GO:0051054),1/108,0.655784495916457,0.735542069744134,0,0,0.944021087946322,0.398304262668659,TRIM28
Positive Regulation Of Metabolic Process (GO:0009893),1/108,0.655784495916457,0.735542069744134,0,0,0.944021087946322,0.398304262668659,G0S2
Lipid Transport (GO:0006869),1/108,0.655784495916457,0.735542069744134,0,0,0.944021087946322,0.398304262668659,SLC10A3
Apoptotic Process (GO:0006915),2/228,0.656875373613248,0.735936864025641,0,0,0.893075449320317,0.375324753344006,PLK3;DDIT4
Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),1/109,0.659176109372816,0.737684724646432,0,0,0.935232668566002,0.38977181561362,DNAJB2
Negative Regulation Of Inflammatory Response (GO:0050728),1/111,0.66585991227406,0.741392198462832,0,0,0.918135198135198,0.373383524585867,SIGLEC10
Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),1/111,0.66585991227406,0.741392198462832,0,0,0.918135198135198,0.373383524585867,STRAP
Regulation Of Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0017015),1/111,0.66585991227406,0.741392198462832,0,0,0.918135198135198,0.373383524585867,STRAP
Mitotic Sister Chromatid Segregation (GO:0000070),1/111,0.66585991227406,0.741392198462832,0,0,0.918135198135198,0.373383524585867,NCAPH2
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),2/232,0.666210861068508,0.741392198462832,0,0,0.877364410578216,0.356340722158963,DDX21;MAP3K14
Protein Deubiquitination (GO:0016579),1/112,0.669152747146142,0.743834973390131,0,0,0.90981750981751,0.365512746083339,JOSD1
Translation (GO:0006412),2/234,0.670801740195678,0.744836714866104,0,0,0.869712051190899,0.347260067022513,RPL10;MRPL55
Regulation Of Protein Ubiquitination (GO:0031396),1/113,0.67241329595988,0.744965119884361,0,0,0.901648351648352,0.357848094652819,DNAJB2
Positive Regulation Of Cellular Component Organization (GO:0051130),1/113,0.67241329595988,0.744965119884361,0,0,0.901648351648352,0.357848094652819,GPX1
Inflammatory Response (GO:0006954),2/236,0.675341664474876,0.745226252720664,0,0,0.862190501365759,0.338441281898309,GGT5;CXCL8
Regulation Of Cytoskeleton Organization (GO:0051493),1/114,0.675641873701566,0.745226252720664,0,0,0.893623780349444,0.350382838899642,STMN3
Regulation Of Interleukin-6 Production (GO:0032675),1/114,0.675641873701566,0.745226252720664,0,0,0.893623780349444,0.350382838899642,HYAL2
Regulation Of MAP Kinase Activity (GO:0043405),1/114,0.675641873701566,0.745226252720664,0,0,0.893623780349444,0.350382838899642,HYAL2
Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),1/115,0.678838792397101,0.747924156225124,0,0,0.885739991003149,0.343110516402242,YIF1B
Positive Regulation Of DNA-templated Transcription (GO:0045893),11/1243,0.679726529240139,0.74807472168307,0,0,0.896332046332046,0.346042184602378,NR4A2;KLF10;TRIM28;HYAL2;NOTCH4;ALYREF;TP53INP2;PTOV1;DDX21;HES1;SSBP3
Cellular Response To Molecule Of Bacterial Origin (GO:0071219),1/117,0.685138884838979,0.75236861003266,0,0,0.870380194518126,0.329120091786434,CXCL8
Protein Maturation (GO:0051604),1/117,0.685138884838979,0.75236861003266,0,0,0.870380194518126,0.329120091786434,F12
Regulation Of Protein Binding (GO:0043393),1/118,0.688242667251436,0.754114077648438,0,0,0.862897216743371,0.322390298845833,DNAJB2
Positive Regulation Of Cell Cycle Process (GO:0090068),1/118,0.688242667251436,0.754114077648438,0,0,0.862897216743371,0.322390298845833,NCAPH2
Cilium Assembly (GO:0060271),2/243,0.690833542975424,0.754989851160955,0,0,0.836848184112589,0.309513637624059,FUZ;ENKD1
Regulation Of Protein-Containing Complex Assembly (GO:0043254),1/119,0.691316008291958,0.754989851160955,0,0,0.855541069100391,0.315830034893024,HSPA5
Positive Regulation Of Angiogenesis (GO:0045766),1/119,0.691316008291958,0.754989851160955,0,0,0.855541069100391,0.315830034893024,CXCL8
Regulation Of Protein Catabolic Process (GO:0042176),1/122,0.700356338103924,0.762355095903287,0,0,0.834202161474889,0.297114462917739,GPX1
Protein Localization To Nucleus (GO:0034504),1/122,0.700356338103924,0.762355095903287,0,0,0.834202161474889,0.297114462917739,NXT1
Receptor-Mediated Endocytosis (GO:0006898),1/122,0.700356338103924,0.762355095903287,0,0,0.834202161474889,0.297114462917739,CXCL8
Regulation Of Cell Motility (GO:2000145),1/123,0.703310854790402,0.764735383593057,0,0,0.827322404371585,0.291181333759909,OSGIN1
Cellular Response To Lipopolysaccharide (GO:0071222),1/124,0.70623638665826,0.766243399903733,0,0,0.82055451323744,0.285393185860525,CXCL8
Positive Regulation Of Defense Response (GO:0031349),1/124,0.70623638665826,0.766243399903733,0,0,0.82055451323744,0.285393185860525,HYAL2
Protein Targeting (GO:0006605),1/129,0.72043907937617,0.779953612020288,0,0,0.788301282051282,0.258479591960958,YIF1B
Regulation Of DNA Repair (GO:0006282),1/129,0.72043907937617,0.779953612020288,0,0,0.788301282051282,0.258479591960958,TRIM28
Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),1/130,0.723196548016167,0.781240522585794,0,0,0.782150665871596,0.25347488505072,HES1
Regulation Of Cell Cycle Process (GO:0010564),1/130,0.723196548016167,0.781240522585794,0,0,0.782150665871596,0.25347488505072,PLK3
Circulatory System Development (GO:0072359),1/132,0.728630565599967,0.786257901774179,0,0,0.770131141123508,0.243814619758579,NOTCH4
Negative Regulation Of Cell Motility (GO:2000146),1/133,0.731307640544709,0.788292651496244,0,0,0.764257964257964,0.239152411422412,FUZ
Regulation Of Protein Kinase B Signaling (GO:0051896),1/136,0.739182231697696,0.795919462455033,0,0,0.747160493827161,0.22579996769063,HYAL2
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),1/137,0.741755731207177,0.79782797870664,0,0,0.741628959276018,0.221550744623754,EIF4A3
Ras Protein Signal Transduction (GO:0007265),1/144,0.759076468093961,0.814698450669812,0,0,0.70507441276672,0.194355706604394,TAX1BP3
Actin Filament Organization (GO:0007015),1/144,0.759076468093961,0.814698450669812,0,0,0.70507441276672,0.194355706604394,MYO7B
Positive Regulation Of Protein Kinase Activity (GO:0045860),1/145,0.761454626646349,0.816371160537959,0,0,0.70014245014245,0.190806106003306,NAB2
Regulation Of Cold-Induced Thermogenesis (GO:0120161),1/146,0.763809428850944,0.817136617761052,0,0,0.695278514588859,0.187333729051167,G0S2
Neuron Projection Morphogenesis (GO:0048812),1/146,0.763809428850944,0.817136617761052,0,0,0.695278514588859,0.187333729051167,LLGL1
Negative Regulation Of Protein Metabolic Process (GO:0051248),1/147,0.766141102769189,0.818751650598833,0,0,0.690481208289427,0.18393654262125,EIF4A3
Central Nervous System Development (GO:0007417),2/283,0.768041116530915,0.81990241378863,0,0,0.7162563745093,0.189028659556507,NR4A2;DDIT4
Vesicle-Mediated Transport (GO:0016192),3/411,0.770410663339565,0.820142119722417,0,0,0.738951539164889,0.192741895502254,VPS51;MAPK8IP3;EPN2
Skeletal System Development (GO:0001501),1/149,0.77073596793191,0.820142119722417,0,0,0.681081081081081,0.177359928012642,HYAL2
Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),1/149,0.77073596793191,0.820142119722417,0,0,0.681081081081081,0.177359928012642,HES1
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),1/152,0.777460383295861,0.826414665701897,0,0,0.667447784004075,0.168011685004247,ANKRD42
Epithelium Development (GO:0060429),1/154,0.781833941079848,0.830177617607174,0,0,0.658655941008882,0.16210373200802,FUZ
Regulation Of Intracellular Signal Transduction (GO:1902531),2/297,0.790834800797504,0.838840747171794,0,0,0.681775292678665,0.159989604625542,PLK3;VWF
Response To Lipopolysaccharide (GO:0032496),1/159,0.79239729882412,0.839603946413642,0,0,0.637650113599481,0.148376318088351,CXCL8
Regulation Of Macromolecule Metabolic Process (GO:0060255),1/162,0.798489410856122,0.844262689185454,0,0,0.625672877846791,0.140797403049471,YBX3
Mitochondrion Organization (GO:0007005),1/162,0.798489410856122,0.844262689185454,0,0,0.625672877846791,0.140797403049471,ATAD3B
Nitrogen Compound Transport (GO:0071705),1/163,0.800480325468176,0.84547020590276,0,0,0.621779044001266,0.138372775650399,PICK1
Heart Development (GO:0007507),1/171,0.815718933349589,0.859741859911313,0,0,0.592277526395174,0.120638301326599,PRMT1
Metal Ion Transport (GO:0030001),1/171,0.815718933349589,0.859741859911313,0,0,0.592277526395174,0.120638301326599,SLC5A6
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),3/452,0.822967804010267,0.866465045237025,0,0,0.670055506191075,0.130552408290438,NAB2;ZNF653;GZF1
Regulation Of Apoptotic Process (GO:0042981),5/705,0.824813102611495,0.867490866104592,0,0,0.714435302916978,0.137599139540915,PLK3;RPL10;HSPA5;OSGIN1;MAPK8IP3
Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),1/179,0.829799142027187,0.870805974977778,0,0,0.56542783059637,0.105492777885955,NECAB2
Protein Modification Process (GO:0036211),5/711,0.830329178887643,0.870805974977778,0,0,0.708141138780535,0.131666845833951,UBL4A;TAF13;TP53INP2;PICK1;RCE1
Intracellular Protein Transport (GO:0006886),2/325,0.830588028342258,0.870805974977778,0,0,0.621780345344866,0.115415714041815,NXT1;PICK1
RNA Splicing, Via Transesterification Reactions With Bulged Adenosine As Nucleophile (GO:0000377),1/180,0.831482157172453,0.870826738742127,0,0,0.562240366709641,0.103758895399928,EIF4A3
Protein-Containing Complex Assembly (GO:0065003),2/328,0.834419240614144,0.872984835768579,0,0,0.615963569666688,0.111501304271573,HES1;LLGL1
RNA Processing (GO:0006396),1/183,0.836432498254272,0.874172894293027,0,0,0.552888137503522,0.0987510501669133,PRMT1
Phosphate-Containing Compound Metabolic Process (GO:0006796),1/184,0.838050245680805,0.874945539515809,0,0,0.549838867871655,0.0971440033114801,IMPA2
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),1/186,0.8412381377873,0.877354120666127,0,0,0.543839223839224,0.0940191962958693,CXCL8
Negative Regulation Of Gene Expression (GO:0010629),2/336,0.844257865332341,0.878773392449483,0,0,0.600963022408791,0.101741419140103,CXCL8;EIF4A3
Axonogenesis (GO:0007409),1/188,0.844363590937906,0.878773392449483,0,0,0.537967914438503,0.0910091522431908,LLGL1
Endocytosis (GO:0006897),1/189,0.845903284116813,0.879456859060904,0,0,0.535079105291871,0.0895456205881801,EPN2
Protein Localization To Membrane (GO:0072657),1/192,0.850432024323559,0.882830604315842,0,0,0.526594173714593,0.0853139405731865,PICK1
Regulation Of Transcription By RNA Polymerase II (GO:0006357),16/2028,0.851876423600961,0.882830604315842,0,0,0.786039319637729,0.126012954520758,KLF10;PLK3;RPL10;NOTCH4;PTOV1;DDX21;NR4A2;HYAL2;ZNF524;HES1;SAMD1;ZNF653;SSBP3;ZSCAN18;GZF1;MXD4
Regulation Of Cell Differentiation (GO:0045595),1/193,0.851911981225013,0.882830604315842,0,0,0.523824786324786,0.0839544806795829,NOTCH4
Positive Regulation Of Gene Expression (GO:0010628),3/480,0.852693816618313,0.882830604315842,0,0,0.629810669012937,0.100363318428362,CXCL8;PRMT1;EIF4A3
Regulation Of Programmed Cell Death (GO:0043067),1/195,0.854828326933477,0.883771958454918,0,0,0.51837166270156,0.0813089888334561,OSGIN1
Positive Regulation Of Cell Population Proliferation (GO:0008284),3/483,0.855607264874684,0.883771958454918,0,0,0.625777202072539,0.0975860816273935,PRMT1;HES1;SLC25A5
Endomembrane System Organization (GO:0010256),1/196,0.856264999908631,0.883771958454918,0,0,0.51568704799474,0.0800219292078688,VPS51
Organic Substance Transport (GO:0071702),1/201,0.863238922493968,0.890047584683222,0,0,0.502666666666667,0.0739240576275295,PICK1
Defense Response To Bacterium (GO:0042742),1/204,0.867260591282566,0.892346641443632,0,0,0.495162308955412,0.0705189268110927,MARCHF2
Regulation Of MAPK Cascade (GO:0043408),1/204,0.867260591282566,0.892346641443632,0,0,0.495162308955412,0.0705189268110927,DUSP2
Regulation Of Angiogenesis (GO:0045765),1/205,0.868574825288997,0.892776600606647,0,0,0.49270990447461,0.0694235854914575,CXCL8
Regulation Of GTPase Activity (GO:0043087),1/214,0.879835307262783,0.90341852168426,0,0,0.471674491392801,0.0603840230274928,STMN3
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),3/525,0.891416008678535,0.91436698727479,0,0,0.574176642248824,0.0659981941886377,VWF;DDX21;MAP3K14
Cellular Response To Lipid (GO:0071396),1/228,0.895473135550058,0.916640537520923,0,0,0.44226815768666,0.0488277567626149,CXCL8
Cilium Organization (GO:0044782),1/228,0.895473135550058,0.916640537520923,0,0,0.44226815768666,0.0488277567626149,FUZ
Positive Regulation Of GTPase Activity (GO:0043547),1/234,0.901538775257083,0.921902074082191,0,0,0.430747221305161,0.0446479080435646,TAX1BP3
Regulation Of Inflammatory Response (GO:0050727),1/240,0.907254112931892,0.926784166706983,0,0,0.419804741980474,0.0408607287973445,HYAL2
Regulation Of Autophagy (GO:0010506),1/241,0.908174042877526,0.926784166706983,0,0,0.418034188034188,0.0402647359420659,GPR137
Cellular Response To Oxygen-Containing Compound (GO:1901701),2/406,0.910184966678779,0.927644373374705,0,0,0.495049504950495,0.0465878416035663,CXCL8;SESN2
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),1/244,0.91087971602456,0.927644373374705,0,0,0.412809960958109,0.0385335086623519,NECAB2
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),1/246,0.912639281353028,0.928063876850601,0,0,0.409398220826792,0.0374249615272022,ANKRD42
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),3/557,0.913155220194366,0.928063876850601,0,0,0.540113353659677,0.049068975014844,TRIM28;NOTCH4;TP53INP2
Organelle Organization (GO:0006996),2/418,0.91846227327006,0.932506038916391,0,0,0.480471847739889,0.0408662684879612,VPS51;ATAD3B
Cytokine-Mediated Signaling Pathway (GO:0019221),1/257,0.921716807914664,0.934857373404282,0,0,0.391586538461538,0.0319210586815877,CXCL8
Phosphorylation (GO:0016310),2/429,0.925417755287395,0.937656240352233,0,0,0.467828774234047,0.0362614158158686,TAF13;PICK1
Regulation Of Protein Phosphorylation (GO:0001932),1/265,0.927723184093362,0.939036881460354,0,0,0.37956487956488,0.0284756722501769,SESN2
Positive Regulation Of Cellular Process (GO:0048522),3/594,0.933334208847148,0.943757230468791,0,0,0.505326004050393,0.034863418035367,PRMT1;HES1;SLC25A5
Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),1/275,0.934590266187918,0.944068869293272,0,0,0.365524985962942,0.0247266920166308,FUZ
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),1/284,0.940213564610864,0.94878694057996,0,0,0.353737428649089,0.0218072874677214,DDIT4
Regulation Of DNA-templated Transcription (GO:0006355),13/1922,0.944994048708702,0.952645822382456,0,0,0.665913833523688,0.0376751733373684,KLF10;RING1;NOTCH4;NAB2;NR4A2;TRIM28;TP53INP2;ZNF524;HES1;ZNF653;ZSCAN18;GZF1;MXD4
Positive Regulation Of MAPK Cascade (GO:0043410),1/310,0.953897824632074,0.960649376474768,0,0,0.323541614803751,0.0152707485753401,NECAB2
Protein Transport (GO:0015031),1/313,0.95526091309998,0.961050373179374,0,0,0.320381328073636,0.0146640995609284,PICK1
Positive Regulation Of Cytokine Production (GO:0001819),1/320,0.958287514724174,0.962382611004595,0,0,0.313238485652279,0.013346285686856,HYAL2
Protein Phosphorylation (GO:0006468),2/500,0.958517620598954,0.962382611004595,0,0,0.399660497660746,0.0169325494515249,TAF13;PICK1
Protein Localization (GO:0008104),1/351,0.969421573398894,0.97235033948167,0,0,0.285040293040293,0.00885212623773901,PICK1
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),1/364,0.973158789691229,0.975116855666463,0,0,0.274648583739493,0.00747264254672471,CXCL8
Positive Regulation Of Multicellular Organismal Process (GO:0051240),1/387,0.978691637773659,0.979675247459863,0,0,0.257977946060848,0.00555649999134502,G0S2
Regulation Of Gene Expression (GO:0010468),5/1127,0.987566152443007,0.987566152443007,0,0,0.435880206437644,0.00545364362835455,CXCL8;GPX1;NAB2;YBX3;GZF1
